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Chronic Plantar Heel Pain (CPHP), commonly known as “plantar fasciitis,” is a 
condition that is estimated to affect 10% of the American population. A treatment for 
CPHP and other soft tissue overuse conditions that is increasing in popularity is the use 
of metal instruments for deep tissue massage for 10 minutes, twice a week for six weeks, 
called the Graston Technique.  
The purpose of this study is to longitudinally examine the foot pain and function 
of participants who received Graston Technique treatment approximately two years 
before this study. A mixed methods design where quantitatively, three self-reported 
survey instruments were utilized, and qualitatively, an interview regarding foot pain and 
function, as well as quality of life, was completed. 
This study is motivated by three research questions: (1) Will participants treated 
with Graston Technique for CPHP report a maintenance or decrease in pain levels two 
years posttreatment? (2) Will participants treated with Graston Technique for CPHP 
report a maintenance or improvement in functional outcomes two years posttreatment? 
(3)What are the lived experiences of participants treated with Graston Technique for 
CPHP? 
The findings of this case series design demonstrate that 13 out of 15 participants 
maintained or improved pain levels and functional outcomes near two years 
posttreatment. Qualitatively, 10 out of 15 of the participants described having foot pain at 
the cessation of treatment, with the pain subsiding a few months later. This could occur 
from the long-term mechanical changes that Graston Technique can impose on 
 
 
degenerated tissue, such as in CPHP. The findings support that Graston Technique may 
be an effective treatment for CPHP to maintain pain and functional levels two years after 
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In recent years, health care professionals in the physical rehabilitation field have 
increased the use of instrument-assisted soft tissue massage (IASTM) with their patients 
in order to treat chronic and sub-acute injuries. IASTM involves the clinician using 
uniquely shaped instruments to perform a deep tissue massage, with the intent of 
facilitating the healing process. One form of IASTM, the Graston Technique 
(TherapyCare Resources, Indianapolis, IN), is defined as: “an advanced form of soft 
tissue mobilization that is primarily used to detect and release scar tissue, adhesions, and 
fascial restrictions” (p. 9).1 It is also theorized that it creates a controlled inflammatory 
response in the body, and enables healing of connective tissues by increasing the number 
of cells that promote healing to the injured area.1,2 One commonly injured area is the 
plantar fascia of the sole of the foot, which can lead to the chronic condition of plantar 
fasciitis. 
 Plantar fasciitis is the common nomenclature used to describe foot pain on the 
plantar surface of the foot, typically where the plantar fascia attaches to the heel bone 
(calcaneus). Use of the suffix “itis" for this condition can be misleading, however, as 
biopsy research has shown that inflammation does not occur.3 It is more correctly a 
degeneration of the plantar fascia tissue, so it in fact, should be referred to as plantar 
fasciosis.4 While many use the term plantar fasciosis or plantar fasciopathy to describe 
this condition, the term chronic plantar heel pain (CPHP)5 is utilized in order to 
2 
 
encompass all the possible pathologies for chronic pain and dysfunction of the plantar 
fascia and calcaneus.  
Statement of the Problem 
 Clinicians are increasingly using IASTM as a treatment modality for overuse and 
chronic soft tissue disorders. IASTM research is greatly limited with the vast majority of 
research articles being individual case studies of various soft tissue injuries, which are 
rated low on the Oxford Scale of Evidence.6 Whereas the amount of evidence is minimal, 
a literature review shows that there is a paucity of research investigating the longitudinal 
outcomes of IASTM, for any specific injury, including CPHP.  
Purpose 
 The purpose of this mixed methods study is to evaluate long term foot pain and 
function of CPHP participants who received Graston Technique with approximately two 
years follow-up (range 21-31 months, mean 25 months). A convergent parallel mixed 
methods design7 will be utilized, which involves concurrent collection of quantitative and 
qualitative data, with independent analysis, and then merging. In this study, three self-
reported outcome instruments will be used and presented as a case series to test the 
theory that Graston Technique maintains long term decreases in pain and increases in 
functional outcomes for participants previously treated with CPHP. The qualitative 
interviews will employ Narrative Inquiry,8 allowing for the same CPHP participants to 
“tell their story” regarding the treatment and longitudinal experience. The purpose for 
amassing both quantitative and qualitative data is to amalgamate the two forms of data to 




 Chronic Plantar Heel Pain involving the plantar fascia resolves 80% of the time 
with conservative treatment,9 however, for some people, symptoms can linger for years. 
Difficult cases are sometimes referred to as “recalcitrant,” meaning “hard to manage” or 
“not responsive to treatment,”10 and were described by DiGiovanni11 as lasting for more 
than 10 months. For some CPHP patients, certain treatments such as corticosteroid 
injections and even surgery provide temporary relief, however, the pain and functional 
limitations return.3 
 The prevailing theory is that plantar fascia degenerates and thickens with CPHP, 
especially after one year post onset of symptoms.5,12 Graston Technique is a deep tissue 
massage that releases scar tissue and adhesions while remolding the fascia,1 which can 
possibly lead to decreased pain with increased function. Currently, there are no studies 
that demonstrate treatment with IASTM resulting in decreased plantar fascia thickness, 
however, studies have reported a correlation between increased plantar fascia thickness 
and increased pain13 with a decrease in thickness after a corticosteroid injection.14 
Whereas, current IASTM literature has described decreases in pain and increases in 
function with immediate results, this study examined participants’ pain and function 
longitudinally for an average of two years after the treatment was completed. 
Research Questions 
 This study examined the longitudinal results of CPHP patients using quantitative 
and qualitative methods. Particularly, the following research questions are addressed: 
4 
 
1. Will participants treated with Graston Technique for CPHP report a maintenance 
or decrease in pain levels two years posttreatment? 
2. Will participants treated with Graston Technique for CPHP report a maintenance 
or improvement in functional outcomes two years posttreatment? 
3. What are the lived experiences of participants treated with Graston Technique for 
CPHP? 
Delimitations 
 This study was restricted to participants of Garrett and Neibert (unpublished data, 
2015) “Graston Technique as a Treatment for Patients with Chronic Plantar Heel Pain: A 
Randomized Controlled Trial,” who completed a 12 session regimen of the investigative 
Graston Technique treatment. The previous study took place from May 2012 to May of 
2013, with 19 participants meeting eligibility requirements for the current study. 
Limitations 
 Efforts will be made to keep limiting factors from affecting the outcome of the 
research. Limitations include: 
1. This study is limited to the perceptions of CPHP patients who participated in a 
study by Garrett and Neibert (unpublished data, 2015). 
2. This study is limited to the participants’ honesty and objectivity of reporting 




3. The participants’ initial diagnosis by a physician was indeed a plantar fascia 
injury, and not an associated differential diagnosis (i.e. nerve entrapment, 
bone spur, or other pathology). 
Definition of Terms 
Instrument Assisted Soft Tissue Massage (IASTM)- A method of deep tissue massage 
utilizing a hand held device made of various materials, and of unique shapes and sizes. 
Chronic Plantar Heel Pain (CPHP)- A term to describe injury to the plantar fascia near or 
at the attachment on the calcaneus (heel bone). A more appropriate term than plantar 
fasciitis, which implies that the plantar fascia is inflamed. 
Graston Technique (GT) – A type of IASTM where a clinician uses stainless steel 
instruments of various sizes with convex and concave shapes to provide a deep tissue 
massage. 
Augmented Soft Tissue Massage (ASTYM)- An alternative type of IASTM where a 
clinician uses plastic instruments of various shapes and sizes to provide a deep tissue 
massage. 
Foot Health Status Questionnaire (FHSQ)- An outcome instrument used to measure self-
reported foot pain, foot function, general foot health, shoes, general health, physical 
activity, social capacity, and vigour. A score of 100 represents optimal health, and zero 
represents worst health. 
McGill Pain Questionnaire (MPQ)- An outcome instrument used to measure self-reported 
pain, by choosing adjectives that describe pain. Participants can score between 0-78, with 
zero representing no pain. 
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Visual Analog Scale (VAS) – An outcome instrument used to measure pain. Participants 






CHAPTER 2  
REVIEW OF LITERATURE 
 The purpose of this review is to evaluate the relevant literature regarding the 
plantar fascia, CPHP, IASTM and the functional outcome instruments utilized: Foot 
Health Status Questionnaire (FHSQ), McGill Pain Questionnaire (MPQ) and Visual 
Analog Scale (VAS). Specifically, foot anatomy and biomechanics will be examined, 
particularly how it pertains to the plantar fascia. Also, CPHP issues, including 
pathophysiology, nomenclature, symptoms, risk factors, rates of occurrence and common 
treatments will be analyzed. This review continues with evidence-based literature 
involving IASTM, specifically Graston Technique and Augmented Soft Tissue Massage 
(ASTYM), and concludes with the three self-reported outcome instruments applied in this 
dissertation. 
Plantar Fascia and Associated Foot Anatomy 
 In anatomical terms, the word ‘plantar’ refers to the sole of the foot, which is 
derived from the Latin word ‘planta’ of the same meaning.15 Fascia is a connective tissue 
located throughout the body, providing covering and structure to muscles, tendons, and 
organs. According to Tabor’s Medical Dictionary16 fascia can be defined in two ways, as 
deep fascia “a fibrous membrane covering, supporting, and separating muscles” or as 
superficial fascia “the subcutaneous tissue that connects the skin to the muscles” (p. 778). 
An aponeurosis is a more organized thickened band of fascia, such as in the palm of the 
hand, or the plantar surface of the foot.17 In many medical references, the term ‘fascia” 
and “aponeurosis” are used interchangeably; Tabor16 defines aponeurosis as “a flat 
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fibrous sheet of connective tissue that attaches muscle to bone or other tissues; may 
sometimes serve as fascia” (p. 151). Therefore, Tabor defines fascia and aponeurosis as 
synonymous, therefore, the term plantar fascia will be used to describe the superficial 
connective tissue on the sole of the foot. 
Historically, many of the great anatomists refer to the plantar fascia indirectly. 
Galen18 circa 175 A.D., described an “outgrowth” on the bottom of the foot from the heel 
that prevents the skin of the sole of the foot from getting folded over. Italian anatomist 
Andreas Velsalius19 (circa 1543), described an “exceedingly thick membrane acting as an 
intimate covering not unlike the broad tendon in the hand” (p. 28). In the drawings of 
Leonardo da Vinci during the early 1500’s,20 da Vinci makes no reference to the plantar 
fascia, as he focuses on the bones and muscles of the foot. 
On the plantar surface of the foot, the plantar fascia lies just beneath the skin 
within the superficial layer of tissues, thusly covering three more layers of muscles at 
deeper levels of the foot.21 After the superficial plantar fascia, Netter21 defines the first 
layer of muscles as the flexor digitorum brevis, abductor hallucis, and abductor digiti 
minimi, which are intrinsic to the foot. The second layer includes the flexor digitorum 
longus and flexor hallucis longus, which are extrinsic, as they are tendinous through the 
plantar aspect of the foot. The second layer also includes the intrinsic lumbrical and 
quadratus plantae muscles. The third and deepest layer of the plantar aspect of the foot 
include the: adductor hallucis, flexor hallucis brevis, and flexor digiti minimi brevis, 
which are all classified as intrinsic muscles. 
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 The plantar fascia originates on the tubercle (bony prominence) of the 
inferomedial surface of the calcaneus.3 It shares an origin more superficial to the skin 
surface to the flexor digitorum brevis, abductor hallucis, and the medial head of the 
quadratus plantae muscles.22 From the origin, the plantar fascia expands anteriorly 
towards the toes, forming a triangular shape.4,22 At approximately the mid-point of the 
foot, the plantar fascia divides into five bands, lengthening anteriorly to become 
continuous with the flexor tendons at the toes.23 More specifically, Hicks24 describes 
insertion points of the plantar fascia at the: deep transverse ligament, the fibrous sheaths 
of the flexor tendons, and the base of the proximal phalanges. 
There are three separate structures of the plantar fascia; the lateral band (away 
from the midline of the body, beneath the 5th toe), the medial band (toward the midline of 
the body, in the medial arch), and the central band, which is often referred to as the 
plantar aponeurosis.23 The lateral band and medial band experience great variation 
between individuals,4,22 to the extent that they are considered insignificant for function 
and injury pathology, therefore, the term plantar fascia typically describes the central 
band.3,4,22 
The foot and ankle involves 26 bones, 34 joints, and over 100 muscles and 
ligaments.25 It is a very dynamic structure that has flexibility to adapt to uneven terrain, 
and it is an unyielding complex withstanding heavy weight bearing loads.25 Houglum and 
Bertoti25 describe the ‘daily functions’ of the foot and ankle as: support of body weight, 
control and balance on standing, regulation on uneven surfaces, compensation for knee 
and hip malalignments, shock absorption with locomotion, elevation with standing on the 
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toes, climbing or jumping, and operating machinery (e.g., operating pedals while driving 
a car). 
 There are three segments of the foot: the rearfoot and midfoot, which both contain 
the tarsal bones, and the forefoot, which contains the metatarsals and phalanges (toes). 
On the plantar surface, these segments comprise three arches; the medial longitudinal 
arch, the lateral longitudinal arch, and the transverse arch. The medial longitudinal arch 
has the greatest length and the highest elevation, as it spans from the 1st metatarsal 
phalangeal joint (ball of the foot) to the calcaneus. The lateral longitudinal arch extends 
from the 5th metatarsal phalangeal joint (little toe) to the calcaneus, and is lower and 
shorter compared to the medial side. The transverse arch traverses the midfoot from 
medial to lateral and is normally concave when the foot is non weight bearing. However, 
during weight bearing, the metatarsal phalangeal joints, or the forefoot, are flexible to 
conform to the shape of the ground or other irregular surface.25  
 Researchers have attempted to define the plantar fascia as a tendon or ligament 
from a histological standpoint, however, some clinicians suggest4 that it is similar to both. 
The midsubstance of the plantar fascia primarily consists of collagen fibers in a wavy or 
crimped pattern.4 Fibrocytes, which are responsible for the production of collagen, are 
embedded amongst the collagen in longitudinal rows. Perry26 describes the plantar fascia 
as “a broad, dense band of longitudinally oriented collagen fibers that are virtually 
nonelastic” (p. 13). 
 When analyzing the histology of the plantar fascia in cadavers, Stecco et al27 
surmised that plantar fascia tissue is comprised of type I collagen fibers that lie 
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longitudinally in a proximal to distal direction, however, a few fibers present in a 
horizontal plane at the proximal and distal insertions. It was also discovered that the 
plantar fascia contains many Ruffini and Pancinian corpuscles, which are 
mechanoreceptors that allow for mechanical pressure or distortion feedback to enter the 
central nervous system. They also propose that these mechanoreceptors allow the plantar 
fascia to prevent muscle overuse in the sole of the foot, “The fascia could be seen as a 
coachman guiding the muscles in the sole of the foot and helping to coordinate all these 
structures during movement” (p. 673).27 
 The plantar fascia is innervated by the tibial nerve as is extends distally through 
the lower leg. At the posterior aspect of the medial malleolus, the tibial nerve splits into: 
the medial calcaneal nerve, the lateral plantar nerve, the first branch of the lateral plantar 
nerve, and the medial plantar nerve.28 The lateral plantar nerve innervates many of the 
intrinsic foot muscles and skin of the lateral one-third of the sole of the foot. The first 
branch of the lateral plantar nerve innervates the abductor digiti minimi, flexor digitorum 
brevis, and quadratus plantae muscles, and has great anatomical variation between 
individuals. It is hypothesized that the first branch of the lateral plantar nerve provides 
the plantar fascia sensory pain at the medial calcaneal tubercle, with pain from 
entrapment of the medal calcaneal nerve being possible, though not as common.29 The 
medial plantar nerve innervates the skin of the medial two-thirds of the sole of the foot, 




 In summary, the foot is a complex system of bones and soft tissue. The plantar 
fascia specifically is a dense band of soft tissue made up of collagen fibers4,26,27 working 
in conjunction with muscles, tendons, ligaments, and bones.21 Whereas it is important to 
understand the anatomy, it is also important to examine the biomechanics of the foot and 
ankle and the relationship of how the soft and bony tissues move upon each other. 
Plantar Fascia Biomechanics 
 Hicks30 created two metaphors regarding the shape of the bones and the 
connections of the soft tissues of the foot. He postulated that the calcaneus, mid-foot, and 
metatarsals formed an arch structure, with the plantar fascia securing the ends. Along 
with the arch, the bone structure of the foot could metaphorically create a “truss” such as 
the roof of a house, with the plantar fascia serving as the “tie beam.”30 His conclusion 
was that both descriptions are accurate, sometimes concurrently, depending on weight 
bearing and if the toes are in extension.30 
 In his landmark study, Hicks24 also created a metaphor for the function of the 
plantar fascia in regards to extension of the toes, describing it as a “windlass” 
mechanism, as regarding to the sail of a maritime vessel. The function of a windlass is to 
pick up the slack in a cable or rope.31 The plantar fascia simulates a rope anchored at the 
calcaneus that traverses the sole of the foot, across the metatarsal phalangeal joint, and 
attaches to tissues at the proximal phalangeal bones at the toes.32 Extension of the toes 
winds the plantar fascia around the metatarsal head, as if a cable is being wound one-
quarter of a turnabout the drum of a windlass,24 thus shortening the distance between the 
calcaneus and the phalanges, and elevating the medial longitudinal arch.32,33 The plantar 
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fascia becomes taut with toe extension (eg, during the propulsion or push-off phase of 
gait while weight bearing) which is considered the foundation of the windlass 
mechanism.32 
 Similarly, it is hypothesized that the plantar fascia functions more as a ‘primitive 
windlass’ or as the hypozomata of an ancient Greek boat, or trireme.31 The hypozomata 
was a tight band of rope attached stem to stern which maintained the integrity of the 
vessel. Veil and Esnault31 studied the height of medial arch of the foot in 60 participants 
while the toes were in neutral, flexion, and extension. In females, the arch on average 
raised 0.6 mm (an increase of 12.18%) during toe extension, while raising 0.8 mm in 
males (an increase of 15.20%), thus confirming that that toe extension tightens the plantar 
fascia and elevates the arch, which is postulated by the windlass mechanism.24 
 Many studies examine the contribution of the plantar fascia to maintain foot 
structure by investigating the medial arch height of the foot after plantar fascia rupture or 
surgical release. Murphy et al34 evaluated the height of the medial, lateral, and transverse 
arches of cadaveric feet after release of the plantar fascia at the origin in one-third 
increments from medial to lateral. They noted a progressive drop in all the arches as each 
one-third of the plantar fascia was severed, with the complete release causing the greatest 
drop in elevation of all the arches. They concluded that a common lateral midfoot pain 
suffered by some patients after plantar fascia release is due to the arches dropping 
causing strain on other supporting structures, specifically the plantar calcaneocuboid 
ligament and joint capsule. 
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 A similar study, conducted by Thordarson et al35 measured arch height and arch 
length in cadaveric feet with the plantar fascia being severed in one-fourth increments 
from medial to lateral. They also added the components of measuring the arch length and 
height not only with the toes at rest or neutral but also with the toes at 30º of extension, 
and at maximal extension. They concluded that there was a progressive decrease in arch 
height and length as a result of each one-fourth release of the plantar fascia, and it was 
also a progressive decrease in the two stages of toe extension, with full release having the 
greatest impact. 
 Huang et al36 investigated twelve cadaveric lower extremities in a neutral 
position, with axial loading of 50, 100, and 150 pounds. The plantar fascia, plantar 
ligaments, and spring ligament were sectioned in certain sequences, and the height of the 
medial longitudinal arch was measured. They deduced that of the three, the plantar fascia 
was the most important in maintaining the medial longitudinal arch, as it held 25% of the 
arch stiffness, compared to 10% by the plantar ligaments, and 2% by the spring ligament. 
 A biomechanical model of the foot deduced that the plantar fascia withstands as 
much as 14% of the entire loading of the foot, leaving the other 86% to the intrinsic 
muscles, the tendons of the extrinsic muscles, and the arch structure itself.37 Also, it is 
presumed the effect of a plantar fascia release lowers the load bearing capacity of the 
foot, leading to faster fatigue of the structure, resulting in a person with flat feet not being 
able to perform a long march.37 
 Chen et al38 examined eight cadaveric specimens, measuring the plantar fascia 
bundle at the midfoot where it splits toward each metatarsal head. Instead of resection of 
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the entire plantar fascia, they resected the medial bundle that progresses to the great toe. 
They concluded that extension of the great toe increases by a mean of 10.16º, without a 
change in medial longitudinal height. Also, they measured that between specimens, the 
2nd bundle was the widest and the thickest; therefore, the medial longitudinal arch could 
be maintained after a first bundle resection. 
 Ker et al39 analyzed one cadaver foot with a device that mimicked the midstance 
phase of gait. They concluded that the plantar fascia can store kinetic energy (strain) in 
the early midstance phase of gait, and produce an elastic recoil in the late phase of 
midstance. It was metaphorically described as “a rubber ball bouncing along” (p. 147), 
and they concluded that running is more energy efficient due to the strain energy stored 
in the medial longitudinal arch. 
In order to discuss the function of the plantar fascia, there needs to be a basic 
understanding of foot and ankle biomechanics. There are two positions that describe foot 
and ankle mechanics during gait: pronation and supination. Of these two positions, they 
are different depending on if the extremity is in weight bearing (closed chain) or non-
weight bearing (open chain). With open chained motion, the talus is fixed in position, 
while in closed chained motion, the talus moves to adapt to stress and terrain.40 
 A weight bearing foot is pronated when there is plantar flexion of the talus on the 
calcaneus, adduction of the talus, medial rotation of the tibia, and calcaneal eversion 
(rearfoot valgus). This is also known as ‘pes planus’ or “flat foot” position.40 Supination 
in weight bearing is the opposite; dorsi flexion of the talus on the calcaneus, abduction of 
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the talus, lateral rotation of the tibia, and calcaneal inversion (rearfoot varus), creating a 
“pes cavus” foot or “high arch.”40  
 In a non-weight bearing (open chained) position, the talus is fixed in position, so 
the calcaneus and foot move about the talus.40 With non-weight bearing supination, the 
foot and calcaneus invert, adduct, and plantar flex in relation to the talus. Again, the 
opposite effect occurs with non-weight bearing pronation, as the foot and calcaneus evert, 
abduct, and dorsi flex at the talus.40 
 Perry26 describes the forces that occur to the heel at different phases of the gait 
cycle. At heel strike, the calcaneus and talus have a valgus or eversion load that 
maximizes at the late stages of midstance, thus the foot and ankle are in pronation. From 
midstance to terminal (push off) phase of gait, the calcaneus and talus begin a varus or 
inversion load, or supination, through the swing phase. Perry postulates that the maximal 
pronation that occurs during the midstance phase minimizes rotatory forces on the ankle 
bones, but causes the greatest strain on the plantar fascia and intrinsic muscles of the 
plantar surface of the foot. He concludes that this can lead to repetitive microtrauma 
causing chronic injury.26 
As described by Hicks,24 the plantar fascia is taught with weight bearing plantar 
flexion, as in the terminal or push off stance of gait, and active or passive great toe 
extension. Gu and Li41 confirmed this in a finite element biomechanical model study, 
surmising that peak stress on the plantar fascia at the push off phase of gait. This force in 




 An in-vivo investigation by Kappel-Bargas et al42 studied the effect of the 
windlass mechanism on gait, by analyzing great toe dorsiflexion on rearfoot motion with 
a biomechanical analysis of twenty participants. Their findings were in agreement with 
Hicks24 in regards to the windlass mechanism, and with Sarrafian33 that calcaneal 
inversion (rearfoot varus) creates elevation of the medial longitudinal arch. Furthermore, 
they were able to differentiate two separate groups within the research participants based 
upon the time the medial longitudinal arch was elevated when the great toe was extended, 
describing them ‘delayed onset’ and ‘immediate onset.’ The authors hypothesized that the 
immediate onset group may be subjected to greater strain on the plantar fascia during 
weight bearing and toe extension, possibly leading to CPHP. Conversely, the delayed 
onset group may be susceptible to overuse injuries, as hyperpronation occurs due to late 
activation of the windlass mechanism.42  
In order to evaluate medial longitudinal arch height during the early and late 
terminal phase of gait (push off), Sharkey et al43 examined arch height in cadavers with 
the normal foot, central plantar fascia band resection, and complete plantar fascia 
resection. A pulley system imitated contraction of the gastroc/soleus complex, tibalis 
posterior, peroneus longus and brevis, and the flexor digitorum muscles. They concluded 
that an intact plantar fascia is the most effective in maintaining the elevation of the 
medial longitudinal arch. With only central band resection, the tension of the tibialis 
posterior muscle was able to support the medial longitudinal arch, but was not able to 
compensate for a complete plantar fascia resection. 
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Erdemir et al44 measured plantar fascia tension in seven cadaveric feet during gait 
with a fiberoptic transducer. A device simulated gait by applying tension to six lower leg 
muscle groups, and approximate body weight was measured on a force plate. They 
determined that plantar fascia tension increased during stance and reached peak tension in 
the late stance phase of gait, with the maximum tension averaging 96% ± 36% of body 
weight. 
A similar conclusion was made by Gefen45 regarding plantar fascia tension, 
however, his methods were in living participants using fluoroscopy, with the elongation 
of the plantar fascia to estimate tension during gait. He concluded that the plantar fascia 
went through the most rapid elongation at the mid-stance of gait, and the elongation was 
significantly slower at terminal stance (push off). 
Scott and Winter,46 in a biomechanical model, estimated that forces on the plantar 
fascia in the mid-stance and push-off phase of walking at 1.3 times body weight, and 2.9 
times body weight during running. Giddings et al47 estimated the loads on the plantar 
fascia at 1.8 to 2.2 times body weight with walking gait and 3.7 to 4.8 times body weight 
during running in a biomechanical analysis of one live subject. As with Scott and 
Winter,46 Giddings et al47 found the peak level of force at the late mid stance phase of 
gait. 
Many researchers are taking note of the importance of the intrinsic muscles during 
plantar fascia loading. Angin et al48 used diagnostic ultrasound to measure the cross 
sectional area of the intrinsic and extrinsic muscles of the foot, as well as the plantar 
fascia, between normal participants and participants suffering from flat feet (pes planus). 
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They discovered that participants with pes planus have a significantly smaller cross-
sectional area and thickness of the abductor hallucis, flexor hallucis brevis, and 
peroneals. The same participants have significantly greater thickness and cross sectional 
area of the flexor digitorum longus and flexor hallucis longus, thus suggesting that these 
extrinsic muscles may hypertrophy to provide medial longitudinal arch support for the 
weaker intrinsic muscles. Also, in the pes planus group, the plantar fascia was 
significantly thinner in the mid and fore foot regions (but not at the origin on the 
calcaneus), thus suggesting reduced load bearing.48 
In summary, the aforementioned paragraphs describe the biomechanical 
importance of the plantar fascia in maintaining medial longitudinal arch structure during 
standing, walking, and running. This gives a sense of how CPHP can be very painful and 
debilitating during physical activity, or occupations that require numerous hours of 
standing. 
Chronic Plantar Heel Pain (CPHP) 
 The term ‘plantar fasciitis’ was first documented by Wood in 1812, however, he 
attributed it to being a side effect of tuberculosis.49 Plantar fasciitis is described as a 
pinpoint tenderness and degeneration of the proximal central band of the plantar fascia.50 
The most common areas of pain are at the plantar fascia insertion at the medial calcaneal 
tubercle,50 and possibly along the medial longitudinal arch.51 It is widely thought that 




 In the past, plantar fasciitis has gone by many other aliases: jogger’s heel, heel 
spur syndrome, plantar fasical insertitis, calcaneal enthesopathy, subcalcaneal bursitis, 
subcalcaneal pain, stone bruise, calcaneal periostitis, neuritis, and calcaneodynia to name 
a few.52 The terms plantar heel pain (PHP) and chronic plantar heel pain (CPHP) have 
been used in recent times, however, some are now using the term heel pain syndrome 
(HPS) as an initial diagnosis.22  
 Hossian and Makwana22 categorize the differential diagnosis for causes of heel 
pain by four categories of foot structures: plantar fascia, other foot soft tissues, calcaneus, 
and nerves. Relative to the plantar fascia itself, heel pain could be caused by a fasciosis at 
the insertion or away from the insertion. A plantar fascia rupture at the origin may also be 
cause of pain. A rare disorder called plantar fibromatosis causes a severe thickening and 
contracture of the plantar fascia; also severe arthritic conditions (e.g. Reiter’s syndrome) 
are rare but may be the cause of heel pain.3 Other soft tissues involved in heel pain could 
be the calcaneal fat pad, an inflamed bursa sac, or tendonitis, most commonly of the 
flexor hallucis longus.22 
 Many calcaneal pathologies can lead to heel pain, such as a calcaneal stress 
fracture, or an infection causing osteomyelitis. Inflammatory conditions such as 
seronegative arthropathy, inflammatory bowel disease, gout, or rheumatoid arthritis could 
also be underlying causes of pain. Benign and malignant cancerous tumors such as 
osteomas, lipomas, and sarcomas, may also be symptomatic. Metabolic disorders 




 Whereas the majority of heel pain can be attributed to plantar fascia pathology, 
Alshimi et al28 attributes nerve entrapment as a possible secondary etiology in difficult 
plantar fascia cases. Entrapment of Baxter’s nerve (first branch of the lateral plantar 
nerve) and the medial calcaneal nerve can be an underlying cause of heel pain, as can 
entrapment of the tibial nerve as with tarsal tunnel syndrome. Finally, a radicular pain 
from the 1st sacral nerve may be the specific pathology22 resulting in heel pain. 
 To summarize, there are a myriad of causes for CPHP, from physical to metabolic 
to systemic. Most commonly, when the connective tissue of the plantar fascia is 
chronically involved, the tissue becomes degenerated3,4 and thickens.5 This leads to a 
controversy in the nomenclature of the condition itself.4 
Plantar Fasciitis vs Plantar Fasciosis 
 Inflammation is a natural process to repair damaged tissues in the body. It is 
typically a three part overlapping process of the initial inflammation phase (1-6 days), 
proliferation phase (3-20 days), and maturation phase (9 days and after).53 The initial 
inflammation is characterized with the common symptoms of: localized heat, redness, 
swelling, pain, and loss of function, which allows for clot formation. The proliferation 
phase entails cells called fibroblasts laying down collagen in the injured area, therefore 
initiating the repair process. Finally, the maturation phase is the process where the 
collagen comes to fruition and typically replaces the injured tissue as scar tissue.53 
Medical terminology has attached the suffix “-itis” to describe this process.54 
 “The term ‘fasciitis’ is a misnomer” (p.587), Ryan3 profoundly states in a 
systematic review of plantar fasciitis treatments in 2008. He infers that past research 
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concludes from a histopathological standpoint, that inflammation is rarely the cause of 
plantar fascia etiology, but rather a degeneration of the tissue, as there is an increase in 
ground substance, collagen fiber disorganization, and increased number of fibroblasts. 
Wearing et al4 agrees, stating: “Consequently, the mechanism underlying the 
development of plantar fasciitis may be related to advanced fascial degeneration, and 
more akin to that of tendinosis (tendon degeneration) than that of tendinitis or insertitis” 
(p. 599). 
 One of the first to histopathologically study plantar fasciitis was Snider et al55 in 
1983. They performed 11 plantar fascia releases in nine long-distance runners with 
chronic plantar heel pain, and a tissue sample was taken from the free end of the plantar 
fascia after resection. Upon histological examination, the specimens were shown to one 
of four histologic variations: collagen degeneration, angiofibroplastic hyperplasia (less 
mature fibrocytes and blood vessels), chondroid metaplasia, or calcification of 
degenerated matrix. The chondroid metaplasia and calcification of degenerated matrix 
could be a result of heel spurs, and they concluded that plantar fasciitis is “the result of 
repetitive collagen microtrauma that causes degeneration with subsequent inadequate 
attempts at repair and healing” (p. 219).55 Leach et al49 performed a similar study on 15 
plantar fascia release surgeries, and found similar results to Snider et al, however he 
described the plantar fascia pathology results as chronic granulomatous tissue and 
mucinoid degeneration. 
 Lemont et al54 examined tissue samples from 50 plantar fasciitis patients and 
found that none of them had signs of inflammation. The authors concluded that the term 
23 
 
plantar fasciosis is more appropriate terminology for the disorder, and that corticosteroid 
injections should be reconsidered as a treatment, as injections might lead to eventual 
plantar fascia rupture.54 
 Fabrikant and Park13 theorized plantar fasciitis versus plantar fasciosis:  
The plantar fasciitis/fasciosis disease process actually constitutes a continuum. 
Perhaps heel pain may begin as a traction and/or pressure plantar fasciitis with 
softening and thickening early onward, where it responds to injections and 
biomechanical rest afforded by orthotics in the form of stretch and pressure 
limitation of the plantar fascia. At an indeterminate future date, as a result of long-
term chronic stretch and focal pressure on the fluid enhanced plantar fascia, the 
plantar fascia develops fiber fragmentation and myxoid degeneration, and morphs 
into plantar fasciosis similar to the Achilles tendinosis (pp. 82-83). 
 
 Whereas plantar fasciitis was first identified to be a degenerative disorder in the 
1980’s,49,55 it was not until the 21st century for authors3,4,13,54 to attempt a change from the 
culture of “plantar fasciitis” to “plantar fasciosis” to “chronic plantar heel pain.” No 
matter what nomenclature is utilized, the condition typically presents the same common 
symptoms and appearance in the healthcare setting. 
CPHP Symptoms and Clinical Presentation 
 The physician’s diagnosis of plantar fasciitis (CPHP) is made by taking a 
thorough patient history accompanied by a detailed physical examination.56 The patient 
history will typically present a gradual, insidious onset of symptoms,3,50,56,57 as CPHP 
rarely results from traumatic onset.3 A very common subjective symptom described by 
the patient is sharp medial arch pain with the first steps out of bed in the morning, or after 
being seated for several hours.3,22,50,56-58 The first steps are most painful and sometimes 
the patient instinctively practices partial weight bearing on that foot, however, usually 
after an indefinite amount of time the pain subsides and the patient can return to normal 
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weight bearing.3,50 The pain may return though, after continued or prolonged standing, or 
increased activity.58 
 Upon the physical examination, there is commonly focal tenderness to palpation 
at the origin of the plantar fascia at the medial calcaneal tubercle.3,50,57-59 However, the 
point tenderness can continue anteriorly to the midfoot,29 and is often referred to as a 
mid-plantar fascia strain.56 The pain can be very intense, to the extent that the patient 
becomes very apprehensive and possibly pulls the foot away from the clinician.57 The 
pain may also be exacerbated by passive dorsiflexion of the digits in the more severe 
cases,3,52,58,59 and this technique is known as the windlass maneuver.57 The clinical exam 
should also include an evaluation for neurovascular disorders; checking for tarsal tunnel 
syndrome, paresthesias, and manual muscle testing.50 Also, other calcaneal disorders, 
such as fat pad atrophy, and calcaneal stress fracture should be investigated.3,50 
 In recent years, diagnostic ultrasound has been used as an imaging instrument to 
assist in the diagnosis of plantar fascia pathology. In a systematic review of imaging for 
CPHP, McMillian et al5 evaluated 11 studies using ultrasound as a diagnostic instrument. 
Based on the meta-analysis, the mean range of non-injured plantar fascia thickness is 
2.17 mm to 4 mm, while the thickness of the ipsilateral, symptomatic plantar fascia has a 
mean range of 2.9 mm to 6.1 mm. Based on this work, with some statistical outliers, it is 
widely accepted that a plantar fascia thickness of 4.0 mm or higher would serve as a 
benchmark for a pathological plantar fascia.5 
 While CPHP symptoms and clinical presentation tend to show a similarity among 
patients, it is also important to understand the risk factors for what part of the patient 
25 
 
population is most susceptible to the condition. However, the literature is not as clear to 
what segment of the population is at most risk for CPHP.  
Risk Factors for CPHP 
 Irving et al60 wrote a systematic review of risk factors for chronic plantar heel 
pain (CPHP). An extensive literature search was performed, followed with a checklist 
system called the Quality Index to rate articles for methodological quality. Due to the 
robustness of the assessment, only 16 articles were used for the review, with Quality 
Index grades of 38-90%, however, 13 of the 16 articles had a grade of 60% or higher. 
With the very rigorous standards, it was found that, from an evidence-based research 
standpoint, many risk factors are inconclusive. Perhaps the strongest evidence (five 
studies) propose that there is correlation between body mass index (BMI) and CPHP in 
the non-athletic population, and that the higher the BMI, the higher the risk for CPHP. In 
regards to age, one article was found to be unbiased, and suggested that there was a trend 
toward the 50-59 age range, and possibly lower into the 40’s, but otherwise no formal 
conclusions could be made. Concurrently no conclusions were made regarding ankle 
range of motion with lack of dorsiflexion, due to limited evidence.60 
 The lack of ankle range of motion, especially foot dorsi flexion, has been widely 
thought to be a contributor to CPHP. Irving et al60 surmised that strong evidence is 
limited with this theory. However, a study by Riddle et al61 concluded via odds ratios that 
participants with 6º-10º of dorsiflexion were 2.9 times more likely to develop CPHP, 




 Foot structure (i.e. cavus foot or planus foot) was inconclusive according to Irving 
et al,60 as results were conflicting and the validity and reliability of measuring static 
calcaneal pitch angle and foot print variables were questionable. Regarding dynamic foot 
motion, results were also inconclusive and conflicting as the evidence was low quality. 
Results of the review were much of the same for the relationship of the first metatarsal 
phalangeal joint extension range of motion and CPHP. In regards to calcaneal spurs, there 
was described a presence of spurs in patients with CPHP, however it is difficult to 
determine if the subject developed CPHP due to the spur first, developed the spur due to 
CPHP, or simultaneously.60 
 The review60 assessed the relationship between prolonged standing and CPHP. 
While there is an association between occupation and long periods of standing, the 
evidence is inconclusive as no uniform definition of prolonged standing or type of 
surface has been established. It was concluded that there is a lack of strong evidence 
regarding risk factors for chronic plantar heel pain, with the best evidence being the 
aforementioned correlation between BMI and CPHP in the non-athletic population. 
 In a systematic review by Beeson,62 risk factor articles were collected for what he 
calls “plantar fasciopathy” and indexed into two subtopics of “Intrinsic” and “Extrinsic” 
risk factors. Intrinsic subtopics were: age, obesity, gender, ethnicity, biomechanical 
dysfunction and anatomical variants, systemic diseases, major trauma, estrogen levels, 
vascular perfusion, antibiotics, and genetic. Extrinsic subtopics were: physical load on 
ligament, occupation, environment, lifestyle, sleep posture, and sport. Beeson62 deduced 
many hypotheses from his review. Plantar fasciopathy typically affects the middle aged 
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and older, as degenerative changes to tissue are common in the aging process. Women 
tend to have higher rates of this condition as compared to men, with no real 
understanding as to why. Beeson agrees with Irving et al60 that BMI over 30 is a risk 
factor in the non-athletic population. Beeson postulates that it is difficult to surmise 
whether the lack of ankle dorsi flexion in the research is a mitigating factor or result of 
the condition, however, some research is suggesting that tight hamstrings may increase 
forefoot loading, therefore increasing the windlass mechanism force on the insertion. 
Finally, Beeson also describes inappropriate footwear, training errors, surfaces, 
hyperpronation, and a general lack of fitness as possible risk factors. 
 In conclusion, in regards to CPHP risk factors there is very little evidence to 
support many theories of what can cause the condition, however, it is agreed that the 
strongest evidence60,62 supports a BMI of over 30 and an age range of 40-60. When 
examining the etiology of CPHP, it is also practical to investigate the incidence and 
prevalence of the condition as well, to know how commonly practitioners encounter this 
condition in the clinical setting. 
Rates of Occurrence of CPHP 
 From 1995-2000, it was estimated by tracking ICD-9 codes that in the United 
States 1,005,000 patients per year sought treatment for plantar fasciitis at primary care 
physician or outpatient hospital clinics.63 However, others have estimated that two 
million or more Americans sought treatment annually for proximal plantar fasciitis 
during the same time period.64 It was also estimated that plantar fasciitis made up 1% of 
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all office visits for orthopedic surgeons, and that 10% of the population suffers from the 
condition at some point in their lifetime.63 
 The economic burden of plantar fasciitis was estimated to be a minimum of $192 
million to a maximum of $376 million in 2007.65 This took into account office visits, 
drugs, and therapy treatments, without including possible diagnostic imaging or surgery 
costs, therefore, the authors deemed this as an underestimation.65 CPHP also places a 
significant financial burden on insurance companies, and can lead to lack of productivity 
and quality of life for paitents.65 For some patients, the symptoms may last long term, 
leading to expensive diagnostic imaging and treatment protocols.65 There is no universal 
agreement on one treatment of choice for plantar heel pain, however, a conservative 
approach to patient management is widely utilized.57 
CPHP Common Treatments 
 While research is increasing regarding heel pain treatments, there is still great 
debate concerning the best management of the condition.50 Many studies suggest, 
regardless of the treatment applied, that 80-85% of plantar heel pain patients will have 
improvement or resolution of symptoms within the first six months of the onset of 
symptoms.9,66 
 In a clinical practice guideline,67 a panel of ten podiatrists created a document 
based on the consensus of current clinical practice and literature review to serve as a 
recommendation for heel pain treatment. This panel created a three “tier” model or 
“ladder” model for plantar heel pain treatment. The first tier or “initial tier” of treatment 
lasts up to six weeks, and includes: padding and strapping, stretching exercises, over the 
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counter arch supports/heel cups, activity modification, shoe recommendations, oral anti-
inflammatories, home cryotherapy, or corticosteroid injection.  
 The second tier of treatments are implemented from approximately the six week 
to six month mark. This includes: a repeated corticosteroid injection, custom orthotics, 
night splints, casting, weight loss, formal physical therapy, or botulinum toxin injection. 
Molloy68 also discusses prolotherapy injections and platelet-rich plasma (PRP) injections 
as options, however, very limited evidence exists as to the effectiveness of these methods. 
The third tier of treatments are for after the six month mark and include: surgery, 
extracorporeal shock wave therapy (ESWT), or re-evaluation of the initial diagnosis. 
 In 2014, the American Physical Therapy Association released clinical practice 
guidelines69 for its members regarding heel pain and plantar fasciitis. Common physical 
therapy treatments for CPHP were evaluated on the best evidence. Many interventions 
received an “A” rating of strong evidence for the large amount of randomized controlled 
trials. This included manual therapy (joint mobilizations and gastrocnemius/soleus trigger 
point therapy), plantar fascia specific and gastrocnemius/soleus stretching, taping of the 
foot to prevent pronation, orthotics, and night splints. Many forms of traditional therapy 
received a “C” rating for low evidence. This includes: low-level laser, phonophoresis, 
and therapeutic ultrasound. Interestingly enough, there is no mention of IASTM (Graston 
Technique, or ASTYM) in the document whatsoever. 
 In a 2014 evidence-based review of plantar fasciopathy treatments for practicing 
Physiatrists, Berbrayer and Fredericson70 rated various treatments using the Australian 
FORM framework for evidence based guidelines. Three treatments were labeled high 
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evidence by the authors: plantar fascia stretching with achilles tendon stretching, 
corticosteroid injection by ultrasound, and ESWT. Many treatments were classified at 
medium evidence, this includes: over the counter arch supports, iontophoresis, arch 
taping, custom orthotics, botulinum toxin A, and night splints. Low evidence treatments 
involved oral non-steroidal inflammatory drugs, acupuncture, and manual therapies that 
include deep tissue mobilization as in the Graston Technique. However, the authors 
write: “the authors theorize that deep tissue mobilization may be an effective adjunct 
therapy for the treatment of subacute plantar fasciopathy ”(p. 163). 
 To summarize, in the three different CPHP clinical practice guidelines of 
Podiatrists, Physical Therapists, and Physiatrists, the use of IASTM is only mentioned 
specifically in the Physiatrist document. While it is hard to ascertain the exact number, 
there are thousands of clinicians in Athletic Training, Physical Therapy, and Chiropractic 
using one of the many forms of IASTM for CPHP, however, it is minimally backed by 
medical research. One treatment that was performed in the initial study of this 
dissertation along with Graston Technique was plantar fascia specific stretching (PFSS). 
Per the Graston Technique manual,1 a treatment regimen consists of a warm up, 
treatment, stretching, and strengthening. Therefore, PFSS was incorporated during every 
treatment session for each investigative group in the initial study. 
Plantar Fascia Specific Stretching (PFSS) 
 As previously stated, there is great debate whether a lack of calf muscle 
(gastrocnemius, soleus, Achilles tendon) flexibility is a factor contributing to chronic 
plantar heel pain.60-62 While it has been reported that 83% of chronic plantar heel pain 
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participants have limited ankle dorsiflexion,71 the debate is if there were range of motion 
restrictions before the injury, or if the deficit is a result of the injury.60, 62 
 In a critically appraised topic paper, Garrett and Neibert72 described how the 
literature does not support gastrocnemius/soleus stretching as a stand-alone treatment for 
CPHP. Similar conclusions were made by Sweeting et al73 in a systematic review of 
stretching as a treatment of plantar heel pain. They concluded that stretching is 
inconclusive as treatment for chronic plantar heel pain, however, stretching of the plantar 
fascia itself tends to be more beneficial than stretching of the gastrocnemius/soleus 
complex. 
 The benefits of plantar fascia specific stretching (PFSS) have been documented in 
four studies. DiGiovanni et al74 randomly assigned 82 chronic heel pain participants into 
a PFSS group, or into an Achilles tendon stretching program. Both groups stretched 10 
times for 10 seconds three times per day, for eight weeks. Results of Foot Function Index 
outcome measure demonstrated a significant difference in pain, activity, satisfaction, and 
increased improvement in the PFSS group. Two years later, a longitudinal follow-up 
study was completed,75 where at the conclusion of the previous study, the participants of 
both the PFSS and Achilles Tendon stretching groups were instructed to incorporate 
PFSS as needed for symptoms. After two years of PFSS, both groups had a significant 
difference in Foot Function Index aspects of: pain at its worst, and first steps in the 
morning pain compared to the baseline score. While there was a significant difference 
between the two groups in the first study after eight weeks, there were no significant 
differences after two years. 
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 A PFSS protocol based upon the DiGiovanni et al studies74,75 was investigated by 
Rompe et al76 in comparison to a group that received three weeks of radial shock wave 
therapy at one time per week. The PFSS group, which performed PFSS three times a day 
for eight weeks, had significant differences in all the variables of the Foot Function Index 
at two months and four months, however, there were no significant differences at the 15 
month follow up. The authors concluded that PFSS was a superior therapy to radial shock 
wave therapy. 
 Since previous studies have documented the benefits of PFSS, Renan-Ordine et 
al77 compared a PFSS group to a PFSS group that also received manual trigger point 
therapy of the gastrocnemius and soleus musculature. Significant differences for the 
trigger point therapy group were reported in the SF-36 Questionnaire outcomes of: 
Physical Function, Bodily Pain, General Health, and Emotional Role. The authors 
suggest that trigger points of the posterior lower leg possible play a role in chronic 
plantar heel pain. 
 Whereas recently, the evidence for PFSS has shown potential for treating CPHP, 
another therapy that has grown in popularity is IASTM, or one specific form of IASTM, 
the Graston Technique. As previously mentioned, stretching directly after treatment is 
recommended during a Graston Technique protocol, with the theory being that the treated 
tissue needs to be stressed in order to promote remolding of the tissue.1  
 The story of how Graston Technique was discovered and developed is quite 
fascinating. It took a great deal of trial, error and development for it to become what it is 
today. Truly, it is a chronical of ‘necessity being the mother of invention.’ 
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Graston Technique History 
 The use of instruments or tools in augmenting massage traces back centuries to 
the gua sha technique in ancient China.78 More recently, the Graston Technique was 
developed by David Graston in the late 1980’s and early 1990’s. David Graston was a 
machinist by trade and also competed as a professional water skier, but in 1987, his 
career was disrupted when he dislocated his knee while water skiing. After a major 
reconstructive surgery and long term rehabilitation, he still lacked normal range of 
motion. He was shown by a therapist how to perform cross friction massage with his 
hands, and while his knee improved, he later had to undergo carpal tunnel surgery from 
performing the massage. This is where he developed the concept of using instruments for 
massage in order to save the providers hands.79 The first prototype Graston developed 
was a wooden roller, which was found to not allow deep massage to the tissue, so the 
next prototype developed was made of aluminum, which progressed to the steel 
instruments.79 The steel instruments provided resonating sensations to the clinician’s 
hands in order find soft tissue lesions that may have not be felt by the injured subject.79 
 In the mid 1990’s, a conflict developed between David Graston and a 
rehabilitation services corporation, which resulted in Graston losing all the rights to the 
concept he created. Currently, the “Graston Technique” belongs to TherapyCare 
Resources of Indianapolis, Indiana,1 while David Graston has created plastic massage 
instruments termed Sound Assisted Soft Tissue Massage (SASTM).79 
 The use of tools to augment soft tissue massage goes back centuries to ancient 
times.78 Within the last 20 years, there has been an increase in use of IASTM by 
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healthcare practitioners.79 With the prevalence of evidence based practice in health care, 
it is imperative to recognize the effect of IASTM on soft tissues, beginning at the cellular 
level. 
Instrument Assisted Soft Tissue Massage and Histological Studies 
 The effects of IASTM on soft tissues of lab rats revert to the late 1990’s. 
Davidson et al80 was one of the first investigations of the long term effect of IASTM on 
soft tissues, as the Achilles tendons of lab rats were studied in four treatment groups. 
However, a different but similar technique to the Graston Technique was applied, using 
Augmented Soft Tissue Massage (ASTYM). ASTYM (Performance Dynamics, Muncie, 
IN) is an IASTM technique that uses plastic instruments and longer strokes than the metal 
instruments of the Graston Technique. The lab rats were separated into four treatment 
groups, a control group, a tendinitis group, a tendinitis with ASTYM group, and an 
ASTYM only group. A tendinitis was created by a procedure of injecting a collagenase 
onto the Achilles tendon. Four treatments were performed post injection on days 21, 25, 
29, and 33 to the ASTYM groups, and tendons were harvested a week after the final 
treatment for analysis. Results showed an increase in fibroblasts in the tendinitis, 
tendinitis with ASTYM, and ASTYM groups, however, there was a significant difference 
in fibroblasts for the tendinitis with ASTYM group compared to the other groups. The 
authors concluded that: “ASTYM may initiate fibroblast activation, which eventually 
leads to collagen synthesis” (p. 318). 
 A similar study was performed on lab rats where they were separated into six 
groups: tendinosis, tendinosis with light ASTYM, tendinosis with medium ASTYM, 
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tendinosis with heavy ASTYM, and a control group. The three ASTYM groups received 
treatment on days 21, 25, 29, 33, 37, and 41, with the Achilles tendons harvested seven 
days after the final treatment. Results showed a significant difference in fibroblast 
recruitment with the tendinosis with heavy ASTYM group, suggesting that the more the 
pressure of the IASTM, the greater the amounts of fibroblasts.81 
 Loghmani and Warden2 also studied IASTM on lab rats, as they severed the 
medial collateral ligament and examined the strength, stiffness, and absorption of energy 
before failure during the healing process. They discovered significant differences in 
strength, stiffness, and absorption for the IASTM group than the control group at four 
weeks post injury with improved collagen formation observed microscopically as well. 
However, when examined at 12 weeks the groups showed minimal differences, with 
stiffness being the only significant difference and with collagen looking the same. The 
authors concluded that in lab rats, IASTM can cause significant early positive changes in 
the healing process, but the healing process stabilizes by the three-month mark. 
 A similar study also examined IASTM on medial collateral ligaments of lab rats, 
using a Doppler scanner to examine perfusion of blood through the healing process. They 
discovered that perfusion and vascularity was significantly more for the IASTM group 
after the 4th and 9th treatment sessions, and one week after the final treatment.82  
 Hammer83 surmises that IASTM provides mechanical loading that stimulates 
fibroblasts in the extracellular matrix, which reproduces collagen, elastin, and other 
growth factors. He continues that with degenerative conditions such as CPHP, IASTM 
produces a controlled inflammatory process that increases blood flow, fibroblasts, and 
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other nutrients, therefore promoting healing. Hammer states: “The effect of Graston 
Technique on reducing pain by decreasing fibrosis might be based on the fact that the 
pain in the plantar fascia is related to the amount of fascial thickness” (p. 254). It is 
hypothesized that the controlled inflammatory process from IASTM in an area of 
excessive fibrosis (e.g. thick plantar fascia) can result in the remodeling of tissues 
through the proper alignment of collagen and elastin fibers.84 
IASTM Publications 
 After an extensive search, the first IASTM study was an abstract published by 
Sevier et al85 in 1995. Forty participants with lateral epicondylitis were randomly 
assigned into a Graston Technique group and an iontophoresis with manual cross friction 
massage group. Participants were tested for third digit eccentric torque, joint angle, 
power, and work with an isokinetic dynamometer, they were also tested for grip strength 
with a hand dynamometer. Participants were tested at 1, 4, 8 and 12 weeks, with results 
showing significant differences and improvements in variables for the Graston Technique 
group within the testing times. There was a significant difference in finger power and 
grip strength between the two treatment groups, however, there was no significant 
differences within the iontophoresis group between the testing times. 
 Currently, there are two known randomized controlled trials utilizing the IASTM 
method ASTYM, which is an IASTM method similar to Graston Technique, however the 
instruments are made of plastic. Wilson et al86 examined twenty participants with patellar 
tendonitis. Participants were randomly assigned to either the traditional treatment 
(stretching, strengthening, modalities, and ice) group, or the same treatments plus the 
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ASTYM treatment group. At the end of the study, all the participants in the ASTYM 
group (10/10) reported complete resolution of symptoms, while a little over half (6/10) in 
the traditional therapy group reported resolution of symptoms. There were no significant 
differences in outcome measures between the two groups. 
 In an additional randomized controlled trial, Sevier and Stegink-Jansen87 
investigated 107 participants with chronic lateral elbow tendonopathy. Participants were 
randomly assigned to ASTYM treatment twice a week for four weeks, or eccentric 
exercise with stretching for four weeks. The ASTYM group had a higher resolution rate 
than the eccentric exercise group, greater gains with the Disability of the Arm Shoulder 
and Hand Scale (DASH) outcome instrument, and greater gains with maximum grip 
strength. The authors concluded that the improvements maintained for 6 and 12 months 
after the study was completed. 
 McCrea and George88 performed a case series on eight participants with various 
knee tendonopathies, by giving them five physical therapy sessions with included 
ASTYM treatment. All the participants showed improvement in the Lower Extremity 
Functional Scale (LEFS) outcome measure, with four of the eight participants describing  
a clinically meaningful improvement in pain scores, and five of the eight with clinically 
meaningful improvement in the LEFS. 
 A retrospective case series89 was also performed on breast cancer patients who 
had a mastectomy, and suffered from a lack of shoulder range of motion due possibly to 
the adhesions at the scar sites. Participants significantly increased their shoulder 
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abduction and flexion from pre testing compared to post. Participants also self-reported 
that they were able to perform more tasks of daily living with less disability. 
 In the meantime, numerous case studies have been published demonstrating the 
benefits of IASTM, however, many of these case studies have had one or more other 
treatment modalities (e.g. rest, manipulation) performed concurrently. The most robust 
case study regarding ASTYM was documented in a study by Melham et al.90 The subject 
was a 20 year old football player with a right ankle that had multiple sprains and two 
orthopedic surgeries. Four months after his second surgery, he started having significant 
pain with activity, and decreased range of motion. He was evaluated to have significant 
loss of function, scar tissue around the ankle joint, and an immature scarring at the 
surgical site. The subject was treated two times per week for seven weeks with ASTYM 
and the normal protocol of range of motion exercises, flexibility exercises, and 
cryotherapy. After the treatment regimen, the subject reported no pain, had increased 
ankle range-of-motion at all planes, and had the appearance of a mature surgical scar on 
his ankle. The authors deduced that the subject’s disability came from excessive (and 
immature) scar tissue formation that was alleviated by the ASTYM technique.90 The 
other ASTYM case studies have published positive benefits for: chronic ankle pain,91 
chronic elbow pain,92,93 carpal tunnel syndrome,94 Achilles tendinopathy,95 after bilateral 
total knee replacement surgery,96 and after patellar fracture surgery.97 
Research specifically for the Graston Technique instruments have taken a similar 
path as ASTYM, with having numerous case studies and limited randomized controlled 
trials. Burke et al,98 studied 26 patients who fit the eligibility criteria for mild carpal 
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tunnel syndrome. Participants were randomly assigned to a Graston Technique group or 
soft tissue mobilization (STM) group, while both groups continued to receive physical 
therapy. The authors assessed the following outcomes: nerve conduction measurements 
of the median nerve via electrodiagnosis, subjective tests including the visual analog 
scale and Katz diagrams, and evaluating manual special tests (i.e. Tinel’s sign, Phalen’s 
test). Measurements were assessed at: baseline, after six weeks of treatments, and three 
months after the last treatment. The results of this study showed that both groups 
improved significantly on all outcome measurements, but not significantly different 
between the Graston and STM groups. They concluded that both manual therapy 
interventions improve the symptoms and signs of carpal tunnel syndrome. However, the 
results do not suggest that Graston Techique is superior over STM, but the toll taken on 
the clinician’s hands may be decreased by using the instruments.98 
In a pilot study involving participants with lateral epicondylitis, Blachette and 
Normand99 randomly assigned 27 participants to a Graston Technique group or a control 
group of lateral epicondylitis education and ergonomic training. They discovered that 
both groups improved with the outcome measures from pretest, posttest, and three month 
follow up, with no significant differences in the outcome variables between groups. 
Looney et al100 treated ten patients suffering from ‘plantar heel pain’ with Graston 
Technique and measured their Global Rating of Change, the Numeric Pain Rating Scale 
(NPRS), and the Lower Extremity Functional Scale (LEFS). Participants had one or two 
treatments a week, for three to eight weeks, averaging a total of 6.9 treatments. Results 
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showed there were significantly more successful outcomes than unsuccessful, and that 
there was also significant improvement in the NPRS and LEFS from baseline to posttests.  
The only currently known randomized controlled trial with the Graston Technique 
used participants with chronic ankle instability. Thirty-six participants were randomly 
assigned to one of three groups. All the groups received dynamic balance training, with 
Graston Technique, sham treatment, and control (no other treatment) being the difference 
between the groups. All the groups showed improvement in the outcome measures of 
Foot and Ankle Ability Measure, range of motion, VAS, and Star Excursion Balance Test 
from pre to posttest, with the Graston Technique group having the greatest increase. 
However, there were no significant differences among the groups.101 
As with the ASTYM technique, the number of case studies regarding the Graston 
Technique are abundant. Benefits have been described with: chronic Achilles 
tendinopathy,83,102 Costochondritis,103 tibialis posterior strain,104 trigger thumb,105 
subacute lumbar compartment syndrome,106 supraspinatus tendonitis,83 ACL 
reconstruction rehabilitation,107 De Quervains tenosynovitis,108 lateral epicondylitis,109 
proximal interphalangeal joint finger injury,110 and after patellar tendon repair surgery.111 
Two case studies regarding Graston Technique and Chronic Plantar Heel Pain 
were discovered. Daniels and Morrell84 treated a 10 year old football player with bilateral 
plantar fasciitis once a week for six weeks. They incorporated chiropractic joint 
manipulation, Graston Technique, stretching and strengthening of the hip flexors, and 
gluteal muscles. After the treatment regimen, the subject reported the end of symptoms 
and increase in activities of daily living. This continued for three months after the last 
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treatment session. Interestingly, the Graston Technique was performed on the 
gastrocnemius and soleus exclusively, and not the plantar fascia itself. 
The other Graston Technique plantar fascia case study was presented by 
Hammer83 on a 50 year old female with symptoms for over three months. She was treated 
twice a week for six weeks, treating the hamstrings, gastrocnemius, soleus, and plantar 
fascia with Graston Technique and stretching, as Achilles tendon tightness was 
considered to be part of the problem. At the conclusion of the treatment, she considered 
herself 95% better, and discontinued treatment. 
Recent literature of IASTM treatment has focused on range of motion, rather than 
injury. Laudner et al112 randomly assigned thirty five asymptomatic collegiate baseball 
players to a Graston Technique treatment group and control group. After one treatment of 
Graston Technique to the posterior shoulder, the intervention group had significantly 
more horizontal adduction and internal rotation range of motion than the control group. 
The contrary was surmised by Vardiman et al113 when examining the effect of Graston 
Technique on range of motion, strength, and muscle biopsies of the gastrocnemius, as 
there were no significant differences in any of the variables examined. They concluded 
that the only effect of Graston Technique was increased pain and loss of function of the 
treatment leg.  
Lastly, Markovic114 evaluated hip and knee range of motion utilizing a different 
IASTM instrument, the Fascial Abrasion Technique (FAT) tool (Niagara Falls, Ontario, 
Canada) on twenty male soccer players compared to foam rolling. He concluded that both 
the FAT tool and foam rolling significantly increased range of motion from baseline, with 
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the FAT tool group having greater gains, and maintaining those gains better over a 24 
hour period than foam rolling. It is important to note that the aforementioned articles 
regarding IASTM and range of motion were after a single application of treatment, while 
the Graston Technique manual1 recommends a protocol of two sessions a week for six 
weeks in order to gain long term effects. 
In summary, much of the IASTM evidence has shown favorable outcomes for 
many conditions, however, most of the IASTM research are case studies that often use 
IASTM in conjunction with a variety of other treatments. Much of the research also used 
a myriad of functional outcomes tests in order to measure change in the participants’ pain 
and function. For this investigation, the Foot Health Status Questionnaire, McGill Pain 
Questionnaire, and Visual Analog Scale outcome assessments were utilized. 
Foot Heath Status Questionnaire 
 There are many instruments to measure the health, pain, and function of the foot 
as well as the ankle. Some examples include the Foot Function Index (FFI), Foot and 
Ankle Disability Index (FADI), Foot and Ankle Ability Measure (FAAM), and Lower 
Extremity Functional Scale (LEFS) to name a few. For this study, the Foot Health Status 
Questionnaire (FHSQ) will be utilized (Appendix A). 
 The FHSQ (Care Quest, Brisbane, Australia) was developed in the mid 1990’s by 
Bennett and Patterson115 in Australia. They described it as an instrument “To measure 
foot health related quality of life” (p. 88). The FHSQ is made up of three sections, with 
the first section containing 13 questions that fall within four domains: foot pain, foot 
function, footwear, and general foot health. The subject answers a Likert scale from one 
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(good foot health, no pain) to five (poor foot health, severe pain). The Foot Health Status 
Questionnaire Data Analysis Software© (Version 1.03) tabulates the answers for the four 
domains and produces a result from 0-100, with zero dignifying a lower state of foot 
health, and the maximum of 100 representing an ideal state of foot health.115 
 The second section is comprised of 20 questions that examine basic measures of 
health in general, and is similar to the common Short Form 36 questionnaire. The third 
section gathers demographic data including: socio-economic status, life satisfaction, and 
co-morbidity. 115 The third section was not relevant for use in this study, as it is 
participant demographic data regarding socioeconomic status, so no data from that 
section was collected. 
 The survey developers used 111 participants to compare the FHSQ to the 
validated Foot-Function Index (FFI), while also studying the test-retest reliability, and 
validity of the FHSQ concurrently.116 It was concluded that the FHSQ has a high amount 
of content, criterion and construct validity, with a Chonbach’s α of 0.85 to 0.88, and test-
reliability of 0.74-0.91. For validity, a goodness-of-fit index was 0.90, and the 
comparative fit index (CFI) was 0.96,116 with the CFI being above the recommended 0.95 
for high content validity.117 
 Landorf and Keenan118 contrasted the FFI and FHSQ to evaluate the health related 
quality of life of plantar fasciitis (CPHP) participants who had been given orthotics after 
four weeks. They concluded that the FHSQ was more responsive to change than the FFI 
in evaluating health related quality of life of the participants treated with orthotics for 
plantar fasciitis. In response to this study, Martin and Irrgang119 in a survey of self-
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reported foot and ankle outcome instruments described that the FHSQ had content, 
construct, and reliability evidence,116 and responsiveness specifically to plantar 
fasciitis.119 
 While statistical significance is commonly used by researchers, there is a concept 
of clinical significance of the subject, where the participants’ perception of whether the 
treatment is beneficial. Landorf and Radford120 examined 175 plantar fasciitis patients, by 
having them complete the FHSQ, FFI, and Visual Analog Scale, also, participants 
completed a ‘global change’ by answering ‘no change’ or ‘a little change.’ The answers 
from the global change were compared to the other instruments in order to calculate a 
minimal important difference. The results for the FHSQ were that Foot pain needed to 
increase by 14, Foot Function by seven, and General Foot Health by nine for there to be a 
minimal clinically important difference for the subject. The Visual Analog Scale minimal 
clinically important difference was nine point improvement as well. 
 While the reliability and validity of the FHSQ is documented and widely 
accepted, Trevethan121 presented some problems with both the FFI and FHSQ. For the 
FHSQ, he questioned the expertise of the panel, which initially created 46 questions 
before narrowing it down to the current 13. He also questioned the redundancy of the 
questions within the domains (especially the pain domain) therefore increasing the 
burden on the participant. He claims that criterion validity has not been assessed, and that 
there is weak evidence of construct validity. While taking these claims into consideration, 
Riskowski et al122 summarizes the FHSO with: “With high validity and an independent 
study assessing minimal important differences, this foot-related patient-reported outcome 
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measure has well detailed psychometric properties and is one of the most common foot 
surveys” (p. S234). 
 In summation, the FHSQ is foot-specific outcome measure which can be more 
sensitive to plantar fascia injuries.119 While the FHSQ measures pain, function, health 
and quality of life, this study also employed two pain specific outcome instruments, the 
MPQ and VAS. 
McGill Pain Questionnaire 
 The McGill Pain Questionnaire (MPQ) was developed in 1975 at McGill 
University, Montreal, Quebec, by prominent pain author Dr. Ronald Melzack.123 The 
instrument consists of a page of 78 words that are adjectives describing pain, which are 
categorized into 20 groups (Appendix B). Participants are instructed to only circle the one 
word that best applies for each group, if none of the words of a group describe the 
participant’s pain, the group should be left blank. Words in each group are scored in a 
hierarchy based on how severe the word describes pain. For example, one group has the 
words: pinching, pressing, gnawing, cramping, or crushing. Pinching is tabulated as one 
point, pressing as two points, gnawing as three, cramping as four and crushing as five 
points, with leaving the group blank serving as zero. Melzack123 has classified the groups 
into three major dimensions of pain: sensory (group 1-10), affective (group 11-15), 
evaluative (group 16), and miscellaneous (group 17-20). A final score is tabulated with 
zero as no pain for the participant, with 78 serving as the maximum level of pain that the 
participant can suffer. 
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 Melzack123 tested reliability of the MPQ instrument by having 10 participants take 
the questionnaire at three different intervals of day 1, 3, and 5, calculating a mean of 
70.3% for the consistency of choosing the same subclasses. Graham et al124 found similar 
results in cancer patients over four intervals with a mean consistency of choosing the 
same subclasses ranging from 66 to 80.4%. In a study of chronic low back pain,125 the 
test-retest reliability co-efficients for the three dimensions of pain were 0.83 overall, with 
sensory being 0.76, affective 0.78, and evaluative 0.47. In a study of 120 participants 
with rheumatoid arthritis, Roche et al126 used the MPQ three times over a six year period, 
there were no significant differences in the scores, with the pain scores remaining 
consistent over the time period. A study127 of six different groups of participants 
immersing their arms in ice water (cold pressor task) produced a remarkable degree of 
consistency with MPQ scores. Pearce and Morley128 used the Stroop color-naming task in 
participants with chronic pain to analyze the MPQ for construct validity, and were able to 
support their hypothesis that the pain participants would select more words than the 
control group. In a study129 of participants with knee osteoarthritis, the MPQ correlated 
with depression, anxiety and fatigue. Hawker et al130 evaluated the MPQ in a systematic 
review of pain scales, and concluded that: “The MPQ is a valid and reliable tool that 
evaluates both the quality and quantity of pain through use of unique pain descriptors” (p. 
S243). 
Visual Analog Scale 
 The Visual Analog Scale (VAS) is a common method used to measure pain 
intensity (Appendix C). The scale entails a piece of paper with a horizontal 10 cm line 
47 
 
with vertical lines on each end. The left vertical line states underneath it “no pain,” while 
the right vertical line states “worst pain imaginable.” The participant is asked to place a 
vertical mark on the horizontal line that best describes the pain in the last 24 hours. A 
metric ruler is used by the clinician to measure from the left or “no pain” side in 
millimeters, registering a score between 0 and 100, with the higher the score representing 
the worst pain.130 
 Reliability for the VAS was high in patients with rheumatoid arthritis,131 with 
literate patients at r=0.94, however, illiterate patients were r=0.71. In a systematic review 
of the VAS for reliability and validation, McCormack et al132 referenced nine articles 
demonstrating validity with other pain scales, with seven out of the nine significant at a 
p=0.05 level. Downie and colleagues133 also showed a strong correlation between the 
VAS, numeric rating scale, and simple descriptive scale, in 100 participants with chronic 
rheumatoid diseases. A systematic review of pain scales used in common pain journals in 
2003, Litcher-Kelly et al134 found the VAS was used most often, at nearly 60% of the 
time. In a systematic review of instruments for measuring pain in rheumatoid arthritis 
participants, Hawker et al130 appraise the VAS as simple and adaptable to many patients, 
and has been widely accepted since the 1970’s. 
Summary 
 At the completion of the review of literature, there are notable conclusions to be 
made that are relevant to this study. First, the plantar fascia is an important connective 
tissue for foot function.24,27,30-32,35-40,42,43 Second, CPHP, in most cases, is a degenerative 
condition of the plantar fascia.3,4,13,49,54,55 Third, IASTM can be utilized as a treatment for 
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degenerative conditions,1,83-87,94,98,99,109 and finally, research for IASTM as a treatment for 
CPHP is limited to three publications in the literature.83,84,100 Therefore, this study 
attempts to fill the void of the shortage of Graston Technique research for CPHP, and 






The objective of this study was to longitudinally measure patient-reported pain 
and function of chronic plantar heel pain participants for an average of two years after the 
conclusion of a Graston Technique treatment regimen. Additionally, a narrative 
perspective of each participant was acquired through a qualitative interview. The research 
design is a mixed methods approach, utilizing the convergent parallel design as described 
by Creswell and Plano-Clark,7 which involves both quantitative and qualitative ‘strands’ 
of data from each participant. Quantitative data was gathered with three pain and function 
instruments and presented as a case series. Dekkers et al135 describes that a case series 
“samples patients with both a specific outcome and a specific exposure” (p. 37). For this 
study, the exposure will be a previous 12 session regimen of IASTM, and the outcome 
will be pain and function measures, along with a qualitative interview of life experiences 
with chronic plantar heel pain treatment.  
 For the qualitative strand, interviews were conducted with the participants to 
provide more detail and give greater insight to their experience with the injury and 
treatment. This design allowed the quantitative and qualitative data to be collected at the 
same time at one meeting. This design places more weight on the quantitative data (pain 
and function instruments), and adds qualitative data (interviews) to enhance the study and 






 A convenience sample of 22 participants with the previous investigation (T.R.G., 
unpublished data, 2015) were recruited in two ways. First, after Institutional Review 
Board (IRB) approval, an announcement was posted in a university wide informational 
email in which interested participants could respond to the principal investigators. 
Second, eight local podiatrists agreed to give an informational pamphlet to patients whom 
were diagnosed with chronic plantar heel pain, with no undue influence or coercion, as 
per IRB protocol. 
 Interested participants would call the primary investigators of the study, and 
answer questions regarding inclusion/exclusion criteria, including contraindications of 
IASTM. Inclusion criteria included: physician diagnosis of chronic plantar fasciitis, 
symptoms for a minimum of three months, and no corticosteroid injections within 30 
days. Exclusion criteria were: diabetes, previous plantar fascia release surgery, and direct 
trauma or acute plantar fascia injury. Contraindications for IASTM are numerous, and 
participants were asked the common contraindications for any manual massage 
technique.1 
Participants were randomly assigned to one of three groups: Graston Technique, 
effleurage, or control at their first visit. Upon the first visit, demographic and consent 
forms were signed, height and weight measured, and pretesting of the Foot Health Status 




Participants were required to complete two sessions a week (not on consecutive 
days) for six weeks, resulting in twelve total sessions. Each session began with five 
minutes of stationary cycling as a warm up. This was followed by the treatment phase of 
the session, with the participant prone on a treatment table with the knee flexed, and the 
plantar surface of the foot exposed. The participants were blinded by hanging a sheet 
from the ceiling to the participants posterior thigh, so they could not visually look and see 
the treatment performed. The Graston group received ten minutes of the investigative 
treatment, which entailed four minutes of instrument #4 (large convex instrument), four 
minutes of instrument #3 (small concave instrument), and three minutes of instrument #2 
(small convex instrument). The effleurage group received eight minutes of light touch 
massage with the clinicians’ fingertips, while the control group received no treatment for 
eight minutes. When the treatment phase of the session was completed, participants 
performed plantar fascia specific stretching (PFSS) where the ipsilateral hand pulls the 
metatarsal head and toes into extension, while the contralateral hand stabilizes the 
calcaneus, as described by DiGiovanni et al74,75 of ten repetitions for ten seconds hold of 
the stretch. Participants were asked to only perform PFSS after the treatment phase, and 
not as part of a home exercise program. 
After the twelfth treatment session, outcome instrument measures (FHSQ, MPQ, 
and VAS) were administered as a posttest. Participants in the effleurage and control 
groups were offered an additional twelve sessions involving the Graston Technique, and 
completed a third set of the outcome measures after completing the phase of treatment.  
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Results of the outcome measures of the three different groups, indicated there was 
a significant difference between group posttests for the FHSQ-Foot Function (P=0.02) 
and visual analog scale (P=0.034) between the Graston and effleurage group. The FHSQ-
General Foot Health scores between the Graston and control groups were significantly 
different (p=0.02), otherwise, there were no other significant differences for the five 
variables among the three groups. 
Current Investigation 
 The first purpose of this study was to ascertain self-reported pain and function 
outcomes of chronic plantar heel pain participants who received the Graston Technique 
from twelve sessions that ended a minimum of 1.5 years ago. This would determine if 
Graston Technique provides long-term relief, as participants in the previous study 
performed posttests after the twelfth treatment. The second purpose of this study was to 
collect qualitative data (via interview) about the participants’ pain and function, as well 
as their attitudes toward their experiences with the healthcare system and CPHP. This 
allows the qualitative data to provide more insight to the quantitative survey instruments 
using the collaborative parallel design, as described by Creswell and Plano-Clark.7 
Upon IRB approval, an attempt was made to contact participants of the previous 
study who completed the Graston Technique phase (n=19) via email or telephone. Fifteen 
chose to take part in the follow-up study, while two declined and two had moved on from 
the last known contact information. A one hour meeting was scheduled at a meeting place 
convenient for the participant. Initially, a qualitative interview (See Appendix D) gave 
the participant the opportunity to describe their past and current foot pain and function, 
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activities of daily living, and treatment experiences. After the interviews were completed, 
participants manually completed the Foot Health Status Questionnaire (FHSQ), McGill 
Pain Questionnaire (MPQ), and Visual Analog Scale (VAS) instruments to measure 
quantitatively the current status of the participants’ chronic plantar heel pain. 
Data Analysis 
 Upon completion, the three survey instruments were analyzed as intended by the 
creators. The FHSQ115, 116 was analyzed by entering the data into FHSQ 2.0 software 
(Care Quest, Brisbane, Australia) that accompanies the written survey when purchased. 
This software calculates eight variable scores of: foot pain, foot function, shoes, general 
foot health, general health, physical activity, social capacity, and vigour.  
 The McGill Pain Questionnaire123 was analyzed using a key that assigned a value 
to each word as created by Melzack. The word that was circled in each group had a value 
of 1-5, and if no words were circled in a group, that value was zero. A word that 
described a higher intensity of pain had a higher value, and a word that described a lesser 
intensity of pain had a lower value. The possible score range of the MPQ is 0-78, with 
zero being no pain reported. 
 The visual analog scale130 is a 10 centimeter line where the participant marks a 
vertical line in between “no pain” and “worst pain imaginable” to describe their current 
foot pain status. Completed VAS data was measured by a third party using a stainless 
steel metric ruler producing a score of 0-100, with zero being no foot pain. Group means 
and standard deviations for the instrument outcomes were calculated using SPSS 
Statistics 23 (Armonk, New York). 
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 The qualitative interviews were all conducted by the same primary investigator, 
recorded with a Sony recorder, downloaded to a laptop, and transcribed to a word 
processor manually using Express Scribe transcription software version 5.69 (NCH 
Software, Greenwood Village, Colorado, USA). Qualitative reporting took place in the 
form of a narrative, where participants ‘tell their story’ regarding their personal 
experience with chronic plantar heel pain before, after, and two years after IASTM 
treatment.136 Emphasis was placed “on ‘what’ is in the story, rather than ‘how’ it is told, 
‘to whom’ and for what reasons” (p.54).8 Therefore, themes regarding the ‘what’ for foot 
pain and function were gathered to provide more in-depth analysis.  
 Transcripts were analyzed and coded for themes. Initially each transcript was read 
to get a sense of the participants’ responses and recognize themes. A second and third 
review was completed to code themes that emerged. The transcript reviews concluded 
with a count of the frequency of themes throughout the interviews. 
Further analysis of amalgamating the quantitative and qualitative data followed 
the work of Creswell and Plano-Clark7 for analyzing mixed methods research. Both sets 
of data converged utilizing the “side-by-side comparison for merged data analysis” 
(p.223) where the quantitative and qualitative results will be presented together so there 
can be easy comparison. This allows for the presentation to be the method for 
communicating the merged conclusions.7 
Trustworthiness 
Trustworthiness was established by utilizing methods of triangulation, negative 
case analysis, member checking, and external audit.7,137 Triangulation established validity 
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by utilizing the three survey instruments that all measured foot pain, and by inquiring 
about foot pain during the interview. This allowed for the participants’ self-reporting of 
foot pain to be compared by four different methods. 
Regarding qualitative validity, Glesne137 describes ‘negative case analysis’ as 
“conscious search for negative cases and unconfirming evidence so that you can refine 
your working hypotheses” (p.37). For this study, negative cases of where participants did 
not respond well to the Graston Technique will be discussed in the results section. 
Further evaluation of these cases may check any personal biases that may appear during 
the study.137 
Trustworthiness of the qualitative data involved the participants to member check, 
and participants were given the opportunity read over their transcribed interview to verify 
accuracy in the message discussed. Finally, the interviews that make up the qualitative 
data underwent an external audit for themes by a member of my dissertation committee, 
who has five years of academic qualitative research experience in the healthcare field. 
This professor verified the themes comprehended from the interviews, by reviewing a 






 The purpose of this study was to determine if participants suffering from CPHP 
who were treated with Graston Technique maintained their decreased levels of pain and 
increased levels of function longitudinally for nearly a two year span after the initial 
treatment ended. Also, this study seeks to establish participants’ affective insights to how 
they perceived the Graston Technique treatment they received in general. 
 Results are presented as a “side-by-side comparison for merged data analysis” 
(p.223) utilizing the convergent design of mixed methods research.7 This is where 
quantitative and qualitative data were acquired at the same time, analyzed independently 
of each other, and then presented together. The data from all 15 participants was merged 
for comparison of the results. 
 A convenience sample of 15 participants (78%) out of an eligible pool of 19 
agreed to participate. Of the four who did not participate, two declined and two had 
moved on from the last telephone number listed from the previous study. The 12 females 
and three males in the current study had an average age of 53.4 (SD ±10.1) years, with a 
range of 30.6 to 72.7 years when the follow-up data was collected. The average amount 
of time from the last treatment in the previous study to the follow-up data collection was 
25.5 months (SD ± 3.2 months), with a range of 21 to 31 months. In the previous study, 
participants reported experiencing CPHP for a self-reported average of 44.33 months (or 
3 years 8 months) with an SD of ± 47.9 (range three months to 144 months). Body Mass 
Index (BMI) had a range of 21.3 to 42.5, with a mean of 30.8 (SD ± 5.9), with 25-29 
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considered overweight, and greater than 30 considered obese. Neither skewness nor 
kurtosis were significant (z>1.96) for any of these variables. Mean results for the seven 
Foot Health Status Questionnaire (FHSQ) variables, McGill Pain Questionnaire (MPQ), 
and Visual Analog Scale (VAS) at pretreatment, posttreatment, and follow-up are 
presented in Table 1. 
 
Table 1: Means and Standard Deviations of pre, post, and follow-up of 
quantitative variables. 
 Pretreatment Posttreatment Follow-up 
Foot Pain 39.6 (±22.7) 78.4 (±11.0) 88.4 (±22.8) 
Foot Function 50.4 (±27.2) 88.7 (±18.8) 91.7 (±24.2) 
General Foot Health 40.8 (±31.1) 69.8 (±20.3) 81.3 (±25.3) 
General Health 80.6 (±21.9) 83.3 (±22.9) 82.7 (±22.2) 
Physical Activity 61.5 (±30.7) 84.4 (±19.6) 87.4 (±21.4) 
Social Capacity 82.5 (±26.2) 94.2 (±13.2) 95.0 (±13.2) 
Vigour 51.6 (±17.1) 62.9 (±11.2) 67.5 (±18.2) 
McGill Pain Questionnaire 29.3 (±13.4) 9.8 (±6.5) 4.8 (±7.8) 
Visual Analog Scale 52.2 (±21.6) 11.9 (±12.3)   7.2 (±18.2) 
For Foot Pain, Foot Function, General Foot Health, Physical Activity, Social Capacity and Vigour, higher scores are optimal. 




 Allen was 45 years old with a BMI of 22.3 when he received the Graston 
Technique in the initial study for CPHP, and he had symptoms for an approximate 
duration of eight months. Quantitative data of the pre, post and follow-up scores for Allen 






Table 2: Quantitative scores for participant "Allen."  
 FP FF GFH GH PA SC Vig MPQ VAS 
Pretreatment 29.3 25 72.5 100 50 75 50 28 37 
Posttreatment 72.5* 81.2* 60 100 77.8 100 75 8 12* 
Follow-Up 100* 100* 85* 100 100 100 75 0 0* 
FHSQ: FP=Foot Pain, FF=Foot Function, GFH=General Foot Health, PA=Physical Activity, SC=Social Capacity, Vig=Vigour. 
Higher scores on the FHSQ signify optimal health. MPQ=McGill Pain Questionnaire, VAS=Visual Analog Scale. Low scores 




 During the interview, Allen described himself as an educator who would be on his 
feet approximately 3-5 hours a day. He described his previous CPHP as making it 
difficult to walk more than ½ a block, and standing on his feet for long periods of time. “I 
found that I would shift my weight to my other foot a lot, and so you are just off balance 
all the time, and I realized I would do it without thinking about it. Just because when you 
have a pain, you try to do things subconsciously to get rid of the pain, and then that 
would just make me uncomfortable overall I think.” 
 After the Graston Technique, Allen described his foot as much better, but some 
pain was still evident. Allen elaborates how the pain eventually went away: 
I can’t pinpoint when this happened, it was a few months afterwards. I remember 
talking to my wife and I said, ‘You know, my heel doesn’t hurt anymore,’ and I 
couldn’t tell you when that happened, I think it was a gradual, the pain went 
away. Because it was not an issue of; ‘oh I woke up one day and it didn’t hurt.’ I 
just noticed that it hadn’t hurt for a long time (laughs) and this is several months 
after the last treatment.  
 
 Allen discusses walking after the treatment ended. “My wife and I would walk a 
lot in the summer. Um, and I found I could go for walks, after the treatment was done, 




 Trudy had suffered from CPHP for approximately two years before participating 
in the previous study. She was age 55 at the time her treatment completed, with a BMI of 
37.6. Trudy’s self-reported pre, post, and follow-up scores are reported in Table 3. 
 
Table 3: Quantitative scores for participant "Trudy."  
 FP FF GFH GH PA SC Vig MPQ VAS 
Pretreatment 31.3 43.8 0 100 55.6 62.5 50 44 35 
Posttreatment 78.1* 81.3* 60* 100 77.8 100 56.3 8 0* 
Follow-Up 87.5 93.8* 72.5* 90 77.8 87.5 81.3 11 8 
FHSQ: FP=Foot Pain, FF=Foot Function, GFH=General Foot Health, PA=Physical Activity, SC=Social Capacity, Vig=Vigour. 
Higher scores on the FHSQ signify optimal health. MPQ=McGill Pain Questionnaire, VAS=Visual Analog Scale. Low scores 
describe less pain, with zero being no pain. * indicates surpassed Minimum Clinical Important Difference: FP>14, FF>7, GFH>9, 
VAS>9. 
 
 Working as a nurse for 8 hours a day used to be excruciating for Trudy. She 
states: “Work was very bad because I’m on my feet all day, and it was just painful I can’t 
even explain.” Once the initial treatment ended, she recalls: “You still knew it was there, 
but it was so much better, oh yeah, so much better, I didn’t have half the pain I had before 
that.” Regarding her current status: “right now, today I have no pain.” When asked about 
her physical activity before the study compared to now, she responded: “Oh my 
goodness, it is so much nicer to go to work and know that I am moving better than a 20 
year old, you know? Then at the end of the day they will say: ‘Oh I hurt, or I am tired’ 
and I say: ‘Oh my gosh you’re half my age.’ I can get home from work now, and I don’t 




 She was asked how she felt she tolerated the Graston Technique, especially the 
first few sessions. “The first couple, yes, yes, I’m not ticklish or anything, but yeah, you 
did tell that after the first two, it may be even a little bruised or felt really sore after and 
so I did have a little tenderness after the first couple. It always felt good, I was very 
happy to come back.” 
Participant “Bonnie” 
 Before participating in the previous study, Bonnie had some of the worst pain 
with the first steps in the morning. “I was having problems just actually when I first got 
up in the morning, walking like, just like to the kitchen or the bathroom. It would, that 
would last for 40 minutes or so, then it would kind of go away and then depended on how 
much walking or standing I did throughout the day. It would come was just really sharp 
pains on the bottom of my foot made it difficult to get around.” She also discussed 
getting cortisone shots: “I was getting cortisone shots on the bottom of my foot, and that 
would help, but soon it kind of wore off and it was back to the same old.” 
 Bonnie had right foot CPHP for approximately 18 months before participating in 
the previous study at age 47, with a BMI 32.3. Bonnie’s quantitative statistics are shown 








Table 4: Quantitative scores for participant "Bonnie."  
 FP FF GFH GH PA SC Vig MPQ VAS 
Pretreatment 66.3 68.8 60 90 94.4 75 50 22 40 
Posttreatment 78.1 93.8* 85* 90 94.4 100 56.3 10 21* 
Follow-Up 100 100 100* 100 100 100 75 0 0* 
FHSQ: FP=Foot Pain, FF=Foot Function, GFH=General Foot Health, PA=Physical Activity, SC=Social Capacity, Vig=Vigour. 
Higher scores on the FHSQ signify optimal health. MPQ=McGill Pain Questionnaire, VAS=Visual Analog Scale. Low scores 
describe less pain, with zero being no pain. * indicates surpassed Minimum Clinical Important Difference: FP>14, FF>7, GFH>9, 
VAS>9. 
 
 Bonnie describes how her foot felt after the initial treatment:  
Well, I think I felt pretty good, cause that was the beginning of school, and I 
would’ve had then… I would’ve jumped right into all of the work that, all of the 
sporting events, and going to even my daughter’s sporting events, so I would’ve 
been active, really active in September and October, and I didn’t have any 
problems. Because if I would’ve, I would’ve probably gone back in to the foot 
doctor again, cause, I wouldn’t of been able to go through another fall like I had 
previously. 
  
 When asked about looking back on her entire health care experience with CPHP, 
she added:  
I didn’t even know that you could do anything besides just go to the podiatrist and 
have them look at your foot, so maybe I wish I would’ve known that I had 
options? That would of negated having to get cortisone shots which are really 
painful and not fun. And uh, it would have been nice to that [Graston Technique] 
because I felt like the cortisone shots were temporary, and then realizing that after 
x amount you might have to have surgery, that was kind of like, that was kind of a 
bummer.  
 
Bonnie concludes: “I know for a fact, and you can ask my husband, I have not had 
any foot problems, which is weird. I just got back from a European trip and probably was 
walking 10 hours a day. Not an issue. I wouldn’t of been able to do that two years ago, 
not at all, there’s no way possible. And I didn’t have to have surgery, and no more shots, 





 Kelly was 57 years old (BMI 30.5) when she participated in the previous study, 
and she reported that she suffered from CPHP for over 4.5 years beforehand. After her 
treatment ended in November of 2012, she reported continuing Graston Technique 
treatments with a local chiropractor for two more months, until January 2013. 
Unfortunately, Kelly reports that her CPHP returned the fall of 2014:  
It seems from 1-10 on a pain scale, it’s probably a three all the time, two to three, 
you know, it’s there, I can feel it, but it’s not deterring…doing anything to stop 
me from doing anything. Before the study, I couldn’t hardly walk on it, I mean the 
getting out of bed it hurt tremendously. Now after the study, if I stretch my heel, I 
can get out of bed, and it’s not deterred me from getting out of bed at all and 
walking right away on it in the morning. 
 
 Kelly described the first few treatments as “hurtful.” 
It was hurting, and I’m thinking I’m not going to do this anymore. It was that 
hurtful, but I thought: ‘no you got to keep doing it just to get it better,’ and it did 
get better and easier, other than it tickled sometimes. Maybe you were just hitting 
the spot, and I guess, it’s no pain, no gain, is what I think. The scar tissue or 
whatever it is that is in there, that you have to break that down. I kind of 
understand the whole concept that if you don’t break it down, and get it dissolved 
out of your body, then it’s not going…I guess that’s what I was thinking but, yeah 
the first couple times it was difficult, it hurt, but after it was fine. 
 
 The quantitative scores for Kelly are displayed in Table 5, she reports that the 








Table 5: Quantitative scores for participant "Kelly."  
 FP FF GFH GH PA SC Vig MPQ VAS 
Pretreatment 29.4 37.5 72.5 100 44.4 87.5 37.5 34 78 
Posttreatment 71.9* 100* 85* 100 77.8 100 68.8 7 19* 
Follow-Up 78.1 81.3 85 90 94.4 100 68.8 4 17 
FHSQ: FP=Foot Pain, FF=Foot Function, GFH=General Foot Health, PA=Physical Activity, SC=Social Capacity, Vig=Vigour. 
Higher scores on the FHSQ signify optimal health. MPQ=McGill Pain Questionnaire, VAS=Visual Analog Scale. Low scores 




 Melissa had suffered from CPHP for about nine months before participating in the 
previous study. She was 70 years old at the time with a BMI of 21.3. Quantitative scores 
for the survey instruments are presented in Table 6 at pre, post, and follow-up. 
 
Table 6: Quantitative scores for participant "Melissa."  
 FP FF GFH GH PA SC Vig MPQ VAS 
Pretreatment 35.6 68.8 25 60 88.9 100 62.5 41 74 
Posttreatment 72.5* 100* 42.5* 60 94.4 87.5 81.3 19 20* 
Follow-Up 93.8* 100 60* 60 100 100 75 10 1* 
FHSQ: FP=Foot Pain, FF=Foot Function, GFH=General Foot Health, PA=Physical Activity, SC=Social Capacity, Vig=Vigour. 
Higher scores on the FHSQ signify optimal health. MPQ=McGill Pain Questionnaire, VAS=Visual Analog Scale. Low scores 
describe less pain, with zero being no pain. * indicates surpassed Minimum Clinical Important Difference: FP>14, FF>7, GFH>9, 
VAS>9. 
 
 In the interview, Melissa described how she had morning pain, but it didn’t affect 
her physical activity:  
Well it would take a while in the morning when I would get out of bed it was 
really, really, sore. It would take a while before I walk normally, and then 
periodically during the day it would be sore as well, so it was just kind of an 
inconvenience and just an irritant. I’m so compulsive, I went ahead and did it 
anyway. I like to walk and sometimes jog a little bit, and I went and did that, but 




 She also explains how her symptoms decreased after the treatment protocol 
ended:  
Well I have to say it was still sore, it was not as sore, but it was still sore. I could 
tell there was some improvement, but then gradually it just went away after that, it 
seemed like you know, it progressively got a little better as time went on…I think 
it was a little bit later that I really noticed an improvement. I noticed a slight 
improvement right when you got done, but then, just a short time later it seemed 
like it just started progressively getting better…I would say in a couple of months 
it was completely, the pain was completely gone. 
 
 Melissa concluded with her thoughts regarding the Graston Technique: “I don’t 
remember that I thought it was very painful. Once in a while you would hit a pain spot 
that was painful. But that was just so brief and you know it didn’t last very long. So I 
guess I didn’t view it as a painful process, just once in a while you would hit a spot that 
was sore.” 
Participant “Susana” 
 Susana was 47 years old when she participated in the initial study. She estimates 
she had CPHP for 12 years previously, and her BMI was 27.6. She explained how the 
condition affected her before the treatment:  
When I would get up in the morning, the pain would be immediate and constant 
throughout the day. It affected my work, it affected what I did, and what I didn’t 
do. I used to walk quite a bit, I had to curtail that because the pain was too much. 
The pain was pretty much constant throughout the day, and I do have job where I 
am on my feet all day. In that respect it affected my work, it affected my 
concentration, because all I could think about was how much pain I was in. 
 
 Susana discussed how her foot felt and the end of the 12 session treatment 
protocol:  
I felt better. I wasn’t completely out of pain which surprised me a little bit, 
because you know, I was hoping this was a miracle thing. So right after the study, 
I felt more positive. I felt that it had worked for me to a certain extent. I was 
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interested in continuing, you know, finding a place in the area where I could 
continue receiving the technique…What I found interesting, one of the reasons 
why I came back to do this part of it, is that I wasn’t completely out of pain right 
after, but I’m pain free right now. What I find interesting is that over time, I 
became less and less aware of the pain, the pain went away, over time. 
 
 She shared her general thoughts regarding receiving the Graston Technique: 
I had some reservations when you first showed me the instrument, and I saw that 
they were super hard metal, and that was one of my concerns was that, wow that’s 
going to hurt. And it did, it did, it felt like, I mean the manipulation felt like a 
bunch of marbles in there getting moved around and bashed around, the funny 
thing was that, I had been hurting for so long, it was painful but it was different 
kind of pain. And in some respects I sort of welcomed it, because I thought 
perhaps, that this feels different, and the not necessarily in a good way, but it was, 
it was good that it was different. I can’t really put it into words, but after the first 
couple of times, and walking around on a now twice sore foot, was a little intense, 
but even from, after the first couple of times, I was already noticing improvement. 
Like I said the pain was different but the different the other kind of pain was a 
whole lot easier to deal with, cause it wasn’t the achy, toothache, ‘oh my God,’ ‘I 
can’t stand this’ kind of thing. It was more a matter of, oh well, you know, this I 
can deal with. 
 
 When asked about her foot function and physical activity level, she responded: “I 
can pretty much do anything I want. I’m not as active as I could be, I’m getting older, I’m 
a little more sedentary in my ways, just because. But if I decided that I wanted to do 
something, I don’t have any compunction about just ‘jetting off’ and doing it.” 









Table 7: Quantitative scores for participant "Susana."  
 FP FF GFH GH PA SC Vig MPQ VAS 
Pretreatment 35.6 50 72.5 60 77.8 100 31.3 26 57 
Posttreatment 78.1* 87.5* 72.5 60 88.9 100 62.5 14 2* 
Follow-Up 72.5 93.8 100* 90 83.3 100 68.8 9 5 
FHSQ: FP=Foot Pain, FF=Foot Function, GFH=General Foot Health, PA=Physical Activity, SC=Social Capacity, Vig=Vigour. 
Higher scores on the FHSQ signify optimal health. MPQ=McGill Pain Questionnaire, VAS=Visual Analog Scale. Low scores 




 Stan was 28 years old with a BMI of 42.5 when he received the Graston 
Technique in the previous study, and he had symptoms for nine months. Quantitative 
scores for the pre, post, and follow-up scores are listed in Table 8. 
Stan describes how CPHP affected him before the treatment: “It really hurt in the 
morning…first step out of bed, it almost brought me to the floor. It’s real shooting pain in 
my heel, really, really, sensitive in the morning and then I would have to limp around a 
little bit. Eventually it would work itself out a little bit, but it would hurt for walking, just 
general walking throughout the day would just hurt. 
 
Table 8: Quantitative scores for participant "Stan."  
 FP FF GFH GH PA SC Vig MPQ VAS 
Pretreatment 35.6 100 42.5 90 100 100 81.3 20 38 
Posttreatment 78.1* 100 100* 100 100 100 56.3 11 15* 
Follow-Up 87.5 100 85 80 83.3 100 68.8 0 0* 
FHSQ: FP=Foot Pain, FF=Foot Function, GFH=General Foot Health, PA=Physical Activity, SC=Social Capacity, Vig=Vigour. 
Higher scores on the FHSQ signify optimal health. MPQ=McGill Pain Questionnaire, VAS=Visual Analog Scale. Low scores 
describe less pain, with zero being no pain. * indicates surpassed Minimum Clinical Important Difference: FP>14, FF>7, GFH>9, 
VAS>9. 
 
 When asked if he CPHP limits him in any way, Stan responded: “Not in any way, 
nope. I’m doing stuff…I’m active. As much as I can do with work, and you know, with 
67 
 
everything like that, so, it’s not even a factor.” He sums his function with: “When I move 
my body, like walking around, and again like active, playing aspect with my kids, or for 
general exercise, I didn’t want to do that as much before, and now, it’s not a barrier at 
all.” 
 Stan describes how he felt after the treatment sessions ended:  
It was a little sore afterwards, but then it eventually went away and I haven’t had 
problems really, since I’d say probably January (2-3 months later) by the latest. I 
probably stopped noticing it. It doesn’t hurt anymore. So I did keep up with some 
of the stretches, that seemed to keep it loose enough. I don’t know if that did 
anything or not. It felt better and then I just kind of stopped doing it because it 
didn’t hurt anymore…I really didn’t feel the morning pain…I would feel a little 
ache every now and then, but eventually, it just disappeared. 
 
 Stan provided insight on his opinion of the Graston Technique:  
I don’t remember being sore, it was sore already. I think it helped more than it 
hurt anything, my foot was sore for those afterwards, and my foot hurt so bad that 
I couldn’t even tell the difference at first maybe, I don’t know. I remember, 
towards the end, that it felt better that you were just like jamming it, and you were 
like “You sure you want me to keep pushing this hard?’ you were asking, and I 
was like ‘Yeah, get in there, get after it.’ It felt better, using those tools, I don’t 
think it was bothersome, but I see how it could be if your feet are more sensitive, 
maybe my feet aren’t sensitive as other people maybe...It felt a little bit better 
when I was doing the placebo portion of the study, then we started using those 
metal tools, then it was like ‘oh wow, this is immediately better,’ I could just feel 
it loosening up, I would absolutely recommend it. 
 
Participant “Stella” 
 Stella was 55 years old when she participated in the previous study. Her BMI was 
26.6 and self-reported that she suffered from CPHP for six years beforehand. The 
quantitative scores of the survey instruments at pre, post, and follow-up is disseminated 




Table 9: Quantitative scores for participant "Stella."  
 FP FF GFH GH PA SC Vig MPQ VAS 
Pretreatment 54.4 75 72.5 90 77.8 100 31.3 15 40 
Posttreatment 84.4* 100* 85* 100 100 87.5 43.8 9 4* 
Follow-Up 100* 100 85 100 88.9 87.5 43.8 1 1 
FHSQ: FP=Foot Pain, FF=Foot Function, GFH=General Foot Health, PA=Physical Activity, SC=Social Capacity, Vig=Vigour. 
Higher scores on the FHSQ signify optimal health. MPQ=McGill Pain Questionnaire, VAS=Visual Analog Scale. Low scores 
describe less pain, with zero being no pain. * indicates surpassed Minimum Clinical Important Difference: FP>14, FF>7, GFH>9, 
VAS>9. 
 
 Stella described how the CPHP affected her physical activity before the study: 
It impacted how I would exercise whether I felt like I could walk or run, or even 
just do a class or aerobic exercise, so there were times I choose not to do exercise 
because I knew it was going to hurt, or it was going to hurt after it was over…I 
don’t think it would make me sit down, or not walk around, but I would know it 
was there. The hard part would be just walking across campus. But I think with 
what the pain would do is keep me from doing anything extended. So if I had to 
stand for a few hours, that wasn’t a big deal to me, I mean it would be painful, or I 
would just forget about it while I was working, I mean, I would know it was there, 
but it wouldn’t impair my work, but it would just be a nuisance. 
 
 Stella continues after the treatment protocol completed:  
It was much better. I felt like I could exercise, it wasn’t going to cause me pain 
afterwards, I didn’t think about it all the time, like I did before.” When asked 
about her current status, she responded: “It’s still good! I haven’t had any pain. I 
probably don’t work out as hard as I used to, I don’t run as much as I used to, just 
because of getting old, but I haven’t thought about it. In fact, when you called me, 
I thought ‘Wow, I haven’t had any pain since then, I really haven’t and I have 
been hiking and walking. 
 
 When asked about her perceptions of the Graston Technique, she responded: “I 
don’t remember it ever being something I couldn’t handle. If there was a little, little 
discomfort as you were working through it. I don’t ever think I ever got to the point 






 Lonnie was 53 years old with a BMI of 28.2, when she consented to take part in 
the previous study. She had experienced CPHP previously for one year, and had 
numerous doctor visits:  
When I got out of bed, I went to step down on the floor, and I didn’t know what 
was going on, and I couldn’t even walk, there was so much pain. So then went to 
XXXXXXX to see Dr. XXXXX, to see if he could help me, and he gave me 
cortisone shots, to get me by and I think it was maybe 3 or 4. It helped, but then it 
came back again, and so he gave me the envelope to see you guys and I said, ‘I 
don’t want to have surgery, if I could go somewhere to have some help, I would 
like that.’ 
 
 The pre, post, and follow-up scores for Lonnie’s CPHP are displayed in Table 10. 
She describes how her foot felt when the previous study ended: “I was very, very, happy. 
Back, like I said, when I got out of bed there was so much pain, and it’s just an absolute 
turn around. I was so excited that you guys could help me out.” 
 
Table 10: Quantitative scores for participant "Lonnie." 
 FP FF GFH GH PA SC Vig MPQ VAS 
Pretreatment 6.3 12.5 0 100 0 100 37.5 10 71 
Posttreatment 100* 100* 100* 100 100 100 50 3 0* 
Follow-Up 100 100 100 60 100 100 18.8 6 0 
FHSQ: FP=Foot Pain, FF=Foot Function, GFH=General Foot Health, PA=Physical Activity, SC=Social Capacity, Vig=Vigour. 
Higher scores on the FHSQ signify optimal health. MPQ=McGill Pain Questionnaire, VAS=Visual Analog Scale. Low scores 
describe less pain, with zero being no pain. * indicates surpassed Minimum Clinical Important Difference: FP>14, FF>7, GFH>9, 
VAS>9. 
  
 Lonnie continues about the current status of her foot: “I’m doing really good, no 
pain, I’m not having any troubles with my foot, not even a little bit of pain or anything, 
I’m just doing my normal, and walking the nature trail now, and I want to get up to the 
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fitness center, and get back on the treadmill and do some things and stuff like that. My 
foot is doing very, very good, very good, this is the best I’ve ever felt.” 
Participant “Kendra" 
 Kendra was 40 years old with a BMI of 27.2, and had suffered from CPHP for six 
years before taking part in the initial study. Her survey instrument scores are in Table 11. 
She described herself as an active runner who was always in pain. 
Before the study I woke up with daily pain. I would have to stretch the moment I 
got out of bed just to be able to walk on my foot. And for a while, I would usually 
walk on the outside of my foot or adjust my gait, until it was stretched and 
warmed up, and then I could go through my day. I would run through the pain, I 
think it probably made it worse. But when I was running, it wasn’t hurting as 
much, it would just hurt after, once it tightened up again. So I was trying to stay 




Table 11: Quantitative scores for participant "Kendra." 
 FP FF GFH GH PA SC Vig MPQ VAS 
Pretreatment 72.5 62.5 25 90 94.4 100 68.8 33 21 
Posttreatment 72.5 93.8* 60* 100 100 100 75 9 15 
Follow-Up 100* 100 85* 100 100 100 75 1 1* 
FHSQ: FP=Foot Pain, FF=Foot Function, GFH=General Foot Health, PA=Physical Activity, SC=Social Capacity, Vig=Vigour. 
Higher scores on the FHSQ signify optimal health. MPQ=McGill Pain Questionnaire, VAS=Visual Analog Scale. Low scores 
describe less pain, with zero being no pain. * indicates surpassed Minimum Clinical Important Difference: FP>14, FF>7, GFH>9, 
VAS>9. 
 
 “When the study ended, it was a lot better, I remember our last appointment, since 
I knew it was my last appointment, I told you to really work it. I do remember it hurting 
for a little while after, and I thought ‘Oh no, I shouldn’t have done that” but within a 




 Kendra discusses if her foot currently affects her activity: “It really isn’t. I still 
run, I’m running a ton.” In regards to the Graston Technique, she adds: “I remember 
asking for it to be a little more aggressive because I really wanted something to work. So 
while I could definitely feel it, it was worth it.” On recommending Graston Technique to 
someone with CPHP: “Absolutely, yes. Because it worked, it helped me, and it was the 
only thing that really helped me move past it.” 
Participant “Marge” 
 Marge was 53 years old when she participated in the previous study, while having 
a BMI of 27.4 and CPHP for 10 years. Her self-reported survey scores on the Foot Health 
Status Questionnaire, McGill Pain Questionnaire, and Visual Analog Score for 
pretreatment, posttreatment, and follow-up are disseminated in Table 12. 
 
Table 12: Quantitative scores for participant "Marge.” 
 FP FF GFH GH PA SC Vig MPQ VAS 
Pretreatment 78.2 75 42.5 50 72.2 87.5 68.8 5 16 
Posttreatment 100* 93.8* 92.5* 100 88.9 100 75 2 3* 
Follow-Up 100 100 85 100 100 100 62.5 1 4 
FHSQ: FP=Foot Pain, FF=Foot Function, GFH=General Foot Health, PA=Physical Activity, SC=Social Capacity, Vig=Vigour. 
Higher scores on the FHSQ signify optimal health. MPQ=McGill Pain Questionnaire, VAS=Visual Analog Scale. Low scores 
describe less pain, with zero being no pain. * indicates surpassed Minimum Clinical Important Difference: FP>14, FF>7, GFH>9, 
VAS>9. 
 
 Marge described having a lot of pain, “I had been in pain for years, and it was a 
lot of limping around, and trying different things, wearing arch supports, and I had 
cortisone injections and tried wearing a boot in bed…It just affected my life, it was hard 
walking, I’d be in pain after I walked, and it was definitely affecting my quality of life.” 
When asked about what aspects of quality of life, Marge continued: “If I was on my feet 
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all day, with my job there were times where I would be out all day long on locations and 
walking and constantly on my feet; that was a guarantee for having a lot of pain at night 
or the next morning when I got up.” 
 When asked if she recalled how her foot felt when the treatment ended, she 
reminiscences: “I really can’t remember if it was like, feeling a lot better at that 
time…but I know that since then, I don’t have, I hardly have any pain at all.” Marge 
responded about her current quality of life:  
Even when I would sit on my desk at work, and I’d stand up, and initially the first 
few steps would hurt. That doesn’t happen anymore, so I can go out and do 
exercise and go for a long walk and not have to worry about the fact that my heel 
is gonna hurt by the time I get to the end of it. When I get up in the middle of the 
night, I don’t, my first thought isn’t oh yeah I have to slip in these shoes I wear 
for comfort, I can actually make a short walk down the hall and not be in pain. So 
I would just I guess the quality of life is that I don’t worry about it anymore. 
 
 Marge expressed her thoughts on receiving the Graston Technique: 
I mean it hurt a little bit, I could feel the grinding, but it wasn’t a pain that was 
uncom-unbearable by any means. It was kind of a, one of those it hurt so good 
kind of things like I knew that it would be good for me (laughs). But it wasn’t at 
all, uncomfortable to a point where I didn’t, would of considered not continuing 
with the treatment.  
 
She would recommend Graston Technique to a friend: “It was simple, non-
invasive, it doesn’t involve drugs.” 
Participant “Ned” 
 Ned was a very active physical educator when he took part in the previous study. 
He was 41 years old, having symptoms for six months, with a BMI of 32. Ned’s 
quantitative scores are in Table 13. 
 Ned was still able to be active, but he was in a lot of pain:  
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Well, it limited me, as far as the training and exercise, I still did the exercise bit I 
was in quite a bit of pain. Quality of life was probably down a little bit because 
I’m on my feet all day for a career, so standing on your feet is what I do, and I 
was dealing with pain all day long…I used orthotics, I’ve had cortisone shorts, 
massage a little bit with physical therapy, a little bit of treatment ionotophoresis, 
pretty much with PT and podiatrists. 
 
Ned described how his foot felt when the Graston Technique therapy ended: 
“Much better, it was pretty much cleared up. I felt and if it was on a scale of 1-10, maybe 
a 2 at that point and time, when we wrapped up.”  
 
Table 13: Quantitative scores for participant "Ned."  
 FP FF GFH GH PA SC Vig MPQ VAS 
Pretreatment 29.4 25 0 100 38.9 75 62.5 51 61 
Posttreatment 78.1* 93.8* 42.5* 90 72.2 87.5 68.8 5 9* 
Follow-Up 100* 100 100* 70 100 100 93.8 0 0* 
FHSQ: FP=Foot Pain, FF=Foot Function, GFH=General Foot Health, PA=Physical Activity, SC=Social Capacity, Vig=Vigour. 
Higher scores on the FHSQ signify optimal health. MPQ=McGill Pain Questionnaire, VAS=Visual Analog Scale. Low scores 
describe less pain, with zero being no pain. * indicates surpassed Minimum Clinical Important Difference: FP>14, FF>7, GFH>9, 
VAS>9. 
 
  When asked about his current foot status, Ned brought up that he does his own 
preventative massage treatment, something that no other participant mentions:  
From what I learned from the study, is, you can put this in there, but I learned 
how to scrape it myself, and I went to Taiwan and bought those gua-sha tools. I’m 
doing preventative maintenance, every morning I probably spend about three/four 
minutes scraping each foot. It’s not come back, I just will do it every morning 
except for weekends I don’t, but five days a week I work on it. There’s no pain, 
and there hasn’t been any pain, I just go over nice and easy, maybe three minutes 
a foot, and that’s it. Spend six minutes a day on it and no pain. 
 
 Ned says he would recommend the Graston Technique to people with CPHP, and 
describes the first few sessions:  
Yeah, I remember the first session was probably the most tender, and it got a little 
bit easier and a little bit easier, right now, it’s very easy with the gua-sha. I’m 
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probably applying more pressure, I am applying more pressure with any of the 
pain. You know, once it gets so severe and chronic, it is a little tougher to start, 
but I don’t remember planning on being there again (laughs), where it’s all 
bunched up like that. 
 
Participant “Nellie” 
 Nellie had suffered from CPHP for 3 months before participating in the previous 
study, she was 51 years old with a BMI of 37.9. Self-reported survey instrument scores 
for Nellie are in Table 14. She described herself as someone who wanted to be active, 
since she spends most of her day sitting at a desk. She describes: “It was affecting my 
workouts, because it’s like I couldn’t…I couldn’t do the push-ups and the planks, and all 
that, because it was so painful. I did the burpees, and if did the burpees I would just be in 
pain for day…It would affect my walking, I would have to kind of almost limp.” 
 
Table 14: Quantitative scores for participant "Nellie."  
 FP FF GFH GH PA SC Vig MPQ VAS 
Pretreatment 12.5 68.8 85 70 72.2 100 75 37 72 
Posttreatment 78.1* 93.8* 60 70 88.9 100 68.8 0 0* 
Follow-Up 93.8 100 100* 90 77.8 100 75 0 0 
FHSQ: FP=Foot Pain, FF=Foot Function, GFH=General Foot Health, PA=Physical Activity, SC=Social Capacity, Vig=Vigour. 
Higher scores on the FHSQ signify optimal health. MPQ=McGill Pain Questionnaire, VAS=Visual Analog Scale. Low scores 
describe less pain, with zero being no pain. * indicates surpassed Minimum Clinical Important Difference: FP>14, FF>7, GFH>9, 
VAS>9. 
 
 When asked about how her CPHP affected her after the treatment regimen ended, 
Nellie responded: “Actually there was little if any effect, it was almost completely gone, 
if not completely gone. I was kind of cautious about doing some things, but then after a 
while it was okay, I didn’t have any pain.” She reports her current status as: “It does not 
affect anything, there is no pain.” 
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 Nellie brought up how the CPHP affected her quality of life. Before the study, she 
describes: “It was disappointing you know, I’ve been trying to work out, I was doing a 
kickboxing workout, and I really enjoyed it, and I was doing it a lot for the enjoyment 
cause I was trying to tone up and lose weight…If I couldn’t work out to the, up to the 
standards that everybody else was, I felt like, I was, failing. I just felt I wasn’t…wasn’t 
giving enough effort.” When asked about her current quality or outlook on life, she 
responded: “It’s a lot better, because I don’t have to face pain everyday.” She was asked 
specifically about kickboxing: “Yeah, I’ve quit that, but I joined a different gym, it 
doesn’t affect anything that I want to do.” 
 When asked about her perception of the Graston Technique the first few sessions, 
she replied:  
Well, I think, I felt some relief while he (investigator) was doing it. I mean it did 
help a lot, it wasn’t really painful, any more painful that what it was. But I could 
tell that there was something that was working because I was able to walk a little 
bit better gradually, over time and then the pain kept going after I repeated 
sessions, the pain you know subsided quite a bit. Like I said, by the end it was 
either gone, or almost gone. 
 
Participant “Sandy” 
 Sandy was 60 years old with a BMI of 32.8 when she participated in the previous 
study, she self-reported that she suffered from CPHP for approximately four months in 
her left foot before receiving the treatment. Quantitative results for the survey 






Table 15: Quantitative scores for participant "Sandy."  
 FP FF GFH GH PA SC Vig MPQ VAS 
Pretreatment 66.3 43.8 42.5 80 50 75 37.5 27 56 
Posttreatment 78.8 87.5* 60* 40 83.3 100 56.3 10 12* 
Follow-Up 100* 100* 85* 90 88.9 100 81.3 0 0* 
FHSQ: FP=Foot Pain, FF=Foot Function, GFH=General Foot Health, PA=Physical Activity, SC=Social Capacity, Vig=Vigour. 
Higher scores on the FHSQ signify optimal health. MPQ=McGill Pain Questionnaire, VAS=Visual Analog Scale. Low scores 
describe less pain, with zero being no pain. * indicates surpassed Minimum Clinical Important Difference: FP>14, FF>7, GFH>9, 
VAS>9. 
 
 Before the study, Sandy had CPHP in her contralateral (right) foot for years, as 
she described: 
I just had what I would call trouble getting up after sitting, some severe pain in 
my left foot. I’d had it in my right foot years before and knew what it was, felt, 
yeah, it’s back in my left foot now. It just made it hard to, to want to walk, move, 
get from place to place, because your foot hurt so bad…I had been walking at the 
Arena, and I was walking two to three miles probably three to four times a week, 
and that had to come to an abrupt stop because of the plantar fasciitis. 
 
Not being able to walk affected her outlook: It was disappointing yeah, because 
the walking actually made me feel better. Made me feel more fit, and I’m not into real 
strenuous exercise, so you know everybody says, ‘well you can get good exercise just 
walking,’ well when you can’t even walk the yeah that’s pretty discouraging.” 
 Sandy describes how her foot felt after the Graston Techique® treatment: “I was 
able to do a lot more. Exercise and not feel badly. Pain had subsided, and I could have a 
more normal life. While we were going through the treatment I was in the process of 
moving from one house to another, so I was doing a lot of work and it helped me get 
through all that because of the treatment I got.” 
 Sandy continues about the current status of her foot:  
I haven’t had any severe problems with it to date. I did start walking a little bit at 
the Arena, and anytime I get any kind of a twinge that I think that, it hurts a little 
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bit or it’s acting up a little bit, I stop. So I haven’t really done a lot of walking for 
exercise. I did this last summer, a little bit, we have a track behind my house and 
since that’s not cement, I thought that would be appropriate for me to walk on so 
I’ve tried to do that…I’d say my outlook on life is better not that I can walk and 
move without pain. I’ve never been a real unhappy person, so I guess I’m just 
going to say that I’m pretty much back to normal! 
 
 Sandy provided interesting feedback about her thoughts with her experience with 
receiving the Graston Technique treatment, “I had something similar done at XXXX 
Hospital Occupational Health, and that was, at that time, very difficult to tolerate. But I 
found with you guys did not so, not so bad. From what I can recall, it’s maybe a little 
uncomfortable, but I’m not gonna say it was really painful.” She states that she did not 
recall exactly what IASTM technique was performed on her at XXXX Hospital 
Occupational Health. 
Participant “Cindy” 
 Not all participants had mostly positive results with the Graston Technique. 
Cindy, a 60 year old with a body mass index of 35.4, had suffered from not just CPHP for 
nine years, but chronic lower extremity pain in her knees and feet most of her adult life. 
The results of Cindy’s pretreatment, posttreatment, and follow-up scores are in Table 16. 
She reported some improvement near the end of treatment, but the pain has returned 








Table 16: Quantitative scores for participant "Cindy."  
 FP FF GFH GH PA SC Vig MPQ VAS 
Pretreatment 12.5 0 0 30 5.6 0 31.3 46 87 
Posttreatment 54.4* 25* 42.5* 40 22.2 50 50 15 47* 
Follow-Up 12.5 6.3 0 20 16.7 50 50 29 71 
FHSQ: FP=Foot Pain, FF=Foot Function, GFH=General Foot Health, PA=Physical Activity, SC=Social Capacity, Vig=Vigour. 
Higher scores on the FHSQ signify optimal health. MPQ=McGill Pain Questionnaire, VAS=Visual Analog Scale. Low scores 
describe less pain, with zero being no pain. * indicates surpassed Minimum Clinical Important Difference: FP>14, FF>7, GFH>9, 
VAS>9. 
 
Cindy describes her pain issues: “Well I had had plantar fasciitis for almost 15 
years, and I have arthritis really bad, but I actually got that from being on my feet I think 
a lot on tile floors, cement floors, and you actually get it from overusing your feet, so. 
Then it just continually got worse and my knees are bad because I have an arthritis 
condition to begin with.” 
She continued with her pain before taking part in the study:  
Well I got so bad that I could hardly walk because I just kept working and I 
should have taken some time off, which you need to take some time off if you get 
really bad and anyway, I got to where I couldn’t hardly walk, so then I had 
surgery on my feet and I ended up not going back to work. So I taught for 35 
years and then I only had six month more to get my, well I had enough time thank 
God, to retire, but I didn’t really recover from that. It was kind of a new surgery 
and then I don’t think they are even using it, it was called the Topaz where they 
put steel wires, like electrical units in the back of your heels and shock it to get 
your…I guess to help your circulation and things like that, but it didn’t work with 
me and it actually made things worse, so. 
 
She had some relief after the Graston Technique regimen was completed:  
I really thought it helped me deal with some of the pain and it seemed like it 
wasn’t quite as think in there. I thought that it really kind of helped, but I have, 
you know, I’m not the normal person, because I had all this knee trouble, I need 
both my knees replaced, so my walking isn’t…I don’t dispense my weight 
correctly when I walk either, cause I have a really bad right knee and I’m just 
chicken to get my knees done. But anyway, that’s kind of my situation, so, but I 




When asked to describe her situation, she responded: “Oh yes, see I have bone spurs, and 
I have a lot of calcium deposits in there, so, and I have a lot of irregular bone growths. 
Actually, I have like three on one foot, and I don’t know, a couple on the other foot, I 
guess.” 
She discusses the current status of her foot:  
Well, I didn’t keep up with any kind of treatments so I’m kind of, I think some 
days are a little bit better, but usually I can walk for, be on my feet for about 10 or 
15 minutes and then it’s still really hot, feels tingly, but I think if a person didn’t 
have all my situational problems, I think it would work a lot better for them, so, I 
mean, I’m, I really haven’t done anything to keep up with that treatment, so, it’s 
kind of just diminished in my opinion. 
 
In regards to how she felt she tolerated the treatment, she continued: “Well, I’m 
always in pain so it didn’t bother me that much, it wasn’t painful to me at all, so. I have 
such a high tolerance to pain from being in pain all the time. But I thought it felt good, 
and that seemed to help my walking, you know, it helped my dexterity a little bit.” When 
asked if she would recommend Graston Technique to someone with CPHP, she 
concluded: “I think that you know, I think it’s helpful I just don’t know that much really 
about it, if you continue doing it on a long term basis. I’m really not sure would it 
completely heal that, I don’t know, because I want to give you honest answers from what 
I knew, for me I thought it helped a little bit, so.” 
Qualitative Themes 
 Many themes emerged from the qualitative interviews. Most participants 
described decreased levels of pain, and increased levels of physical activity since the 
Graston Technique treatment ended, which were compatible with the quantitative scores 
of the three survey instruments. One unexpected theme that surfaced involved 
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participants describing decreased pain, but still apparent, foot pain at the end of the six 
week treatment period, then the pain completely subsided a few months later. Participants 
also described the desire to avoid surgery as a treatment option, and many thought that 
Graston Technique was a favorable treatment. Finally, most participants had not sought 
healthcare or treatment for their CPHP, as the reduction of symptoms and increase of 
function made it unnecessary. 
Summary of Results 
Current Pain Level 
 The pain results had 14 of 15 participants report decreased pain from pre testing 
to two year follow up. Also, 13 out of 15 maintained or reported decreased pain for two 
out of the three outcome instruments from posttest to the follow-up. Mean group scores 
presented a trend of decreased pain from pre, post, and follow-up with the FHSQ, MPQ, 
and VAS. From the qualitative interviews, there were 11 out of 15 participants who 
described being “pain free” at the follow up. Of the 15 participants, 13 described overall 
satisfaction with the decrease in pain, as one participant suffered a re-injury, and one felt 
that they improved at posttest but regressed to the pretest levels during the follow up. 
With the results, it appears that for the majority of the participants, the answer to the 
research question is that decreased pain levels were maintained longitudinally from the 
posttest, and the pain levels continued to slightly decrease during the two year follow up. 
 With the qualitative interviews, 11/15 reported that with the longitudinal follow 
up, they ‘had no pain’ or were ‘pain free,’ but only four reported a 100 on the Foot Pain 
score of the FHSQ, a zero on the MPQ, and a zero on the VAS at the same time. 
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However, participants “Kendra” and “Stella” both reported their pain as a FHSQ of 100, 
MPQ as one, and VAS of one, indicating a very low level of pain. “Lonnie” rated her 
pain as a FHSQ of 100, MPQ of six, and VAS of zero, also indicating a very low level of 
pain. “Marge” had similar scores of FHSO at 100, MPQ as one, and VAS of four. 
“Nellie” on the other hand, rated her MPQ and VAS score as zero, but scored her FHSQ 
foot pain as 93.8. Two participants described themselves as significantly better, but 
suffering from occasional minor pain. One subject was doing well, but suffered a relapse 
of CPHP, while one improved at the end of the Graston Technique, but regressed to 
pretreatment levels longitudinally. 
Minimal Important Difference 
 Landorf and Radford120 describe the minimal important difference as what is 
clinically significant, or the minimal score of an instrument where the participants sense 
the treatment is beneficial, rather than statistically significant. For the FHSQ, the minimal 
important difference scores are Foot Pain > 14, Foot Function >7, and >9 for General 
Foot Health. The Visual Analog Scale was any score greater than nine.120 
 From pretest to posttest of the four variables, eight out of 15 increased in all four, 
while six out of 15 increased in three out of the four variables, leaving one participant 
increasing in two out of the four. From posttest to follow-up, 11/15 produced a minimal 
important difference in at least one variable. Of that 11, two reached with all four 
variables, three in three of the variables, two with two of the variables, and four with one 




Physical Activity Level 
 As previously reported, with the qualitative interviews,10/15 participants reported 
being more physically active during the follow-up than before starting the study, with 
3/15 stating their activity level stayed the same. This is reflected in the survey 
instruments, as 13/15 reported higher “Physical Activity” scores on the FHSQ at follow-
up than pretreatment. Nobody scored exactly the same “Physical Activity” score on 
pretreatment and follow-up, but three participants had a score within six points on a one 
hundred point scale. 
 Qualitatively, at the posttest or cessation of the Graston Technique treatment 5/15 
responded that they became more physically active, while 8/15 were the same physical 
activity, with less pain. When comparing from pretest to follow up, 10/15 described being 
more physically active, with three staying the same. One participant went back to 
pretesting levels, and one is more active, but has to stop after 1.5 miles of walking due to 
a “twinge” on the plantar surface on the bottom of her foot. 
 There were three suppositions that emerged regarding the physical activity level 
of the participants at the posttest, or time of the cessation of the Graston Technique 
treatment. The leading theme by 8/15 participants of their recollection of that time was 
the physical activity stayed the same, but with less pain. There were comments of: “I was 
no longer consciously thinking about it,” “walking felt better,” and “no more pain at 
work.” Five out of the 15 described as immediately becoming more active at the end of 
the treatment protocol, with reports of: “my activity improved significantly,” and “I was 
doing more walking.” Lastly, there were two who had no recollection. 
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Pain at Cessation of Treatment 
 One unexpected theme that emerged involved participants in the interview 
reporting that their pain had diminished during the Graston Technique, but there was still 
minor pain at the cessation of treatment. However, an undetermined amount of time later 
(some describe three to six months) 10/15 participants described their pain as decreasing 
to where many described to the point of negligible, even though treatment had been 
discontinued months before. From the survey instruments, this trend of a consistent 
decrease in pain scores from pretreatment, to posttreatment, to follow-up, was reflected in 
10/15 participants. 
Follow-up Care and Self-treatment 
 After the cessation of treatment, nine of the 15 participants had not performed any 
follow-up self-treatments, while five continued to stretch on their own, and one subject 
was both stretching on their own and had purchased their own IASTM device to perform 
plantar massage every day. The vast majority of participants (13/15) had not engaged in 
formal follow-up healthcare. However, one subject continued Graston Technique with a 
local chiropractor, and one continues to visit her podiatrist. 
Attitude Towards Surgery 
 Many (11/15) voiced their hesitation to undergo plantar fascia release surgery, 
with two that seriously considered surgery, and two that had no opinion. As previously 
mentioned, the plantar fascia provides structural integrity to the foot,24,25,30-33,37,42,44,46,47 
with any amount of release or resection of it leading to a change in foot mechanics.34-39, 43 
Therefore, undergoing plantar fascia release surgery has become controversial.37 
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Attitude Towards Graston Technique 
 All of the participants had a favorable attitude toward the Graston Technique 
received. Some stated that the first few sessions were initially uncomfortable, but 
tolerable. It is important to note that in the previous study before this follow-up that four 
participants dropped out because of hypersensitivity to the treatment on the plantar 
surface of the foot or for excessive pain. The Graston Technique is not tolerated by 
everyone suffering from CPHP, as patients with pain from nerve entrapment, an 
inflammation specifically of the plantar nerves, or a pathological exototic calcaneal heel  
spur may feel an increase in pain and discomfort from the treatment. IASTM may be 
more prudent for CPHP patients with pathology of chronic degenerative plantar fasciosis, 









 The purpose of this study was to examine the longitudinal outcomes of chronic 
plantar heel pain participants for approximately 24 months after the completion of a six 
week Graston Technique regimen. Specifically, data was collected using a mixed 
methods approach of convergent parallel design,7 where quantitative and qualitative data 
were collected simultaneously, and analyzed independently. There were three research 
questions addressed by this dissertation. The first question is “Will participants treated 
with Graston Technique for CPHP report a maintenance of pain levels two years 
posttreatment?” This study used three quantitative survey instruments the FHSQ, MPQ, 
and VAS to measure pain, which were completed pretreatment, posttreatment, and 
approximately two years longitudinally posttreatment. Also, participants were asked to 
qualitatively report their pain during a two year follow-up interview. The second research 
question was “Will participants treated with Graston Technique for CPHP report a 
maintenance of functional outcomes two years posttreatment?” The FHSQ has a sub 
sections of “Foot Function” and “Physical Activity” to answer the research question, as 
well as a specific question about function and physical activity in the qualitative 
interview. The third and final research question is “What are the lived experiences of 
participants treated with Graston Technique for CPHP?” The results were presented as a 
case series, where the qualitative data of narrative interviews provided more depth to the 
quantitative data from the foot health and pain instruments.7 
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 In this study, 13 out of 15 participants maintained or decreased their foot pain, 
and 13 out of 15 maintained or increased their physical activity from posttest over the 
two year longitudinal span. All 15 participants were patients of podiatrists, whom many 
had received the typical treatment plan of rest, activity modification, orthotics, and some 
a corticosteroid injection or multiple injections over time. While this common protocol 
temporary relief, this practice often leads to a return of symptoms, with sometimes a 
rupture of the plantar fascia due to multiple corticosteroid injections.3 The results of this 
study produce a trend of the majority of participants maintaining or having positive 
longitudinal gains to their foot pain and function. Therefore, IASTM may be a treatment 
modality that for many with CPHP could be a viable therapeutic option, and provide long 
term relief. 
 One major finding from the qualitative aspect of this study is that 10 out of 15 
participants reported foot pain continuing to decrease after the treatment had ended. It is 
curious to determine why these participants had decreasing levels of pain for CPHP, even 
though they were not receiving treatment. One possible theory comes from the 
mechanical changes that Graston Technique can make to soft tissue, including the plantar 
fascia. Many postulate that CPHP is a degeneration of the plantar fascia,3,4,13,49,54,55,69,70,130 
causing thickening to abnormal levels, therefore causing pain and loss of function.13,14 
Hammer83 proposes that mechanical treatment of Graston Technique creates a “controlled 
inflammatory process” that promotes the healing process. While authors have not 
hypothesized how Graston Technique effects degenerated tissue specifically, it is 
possible that it has a dual effect on CPHP. First, the mechanical effects of Graston 
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Technique may literally “break up” the degenerated tissue, therefore decreasing the 
plantar fascia thickness. Secondly, the “controlled inflammatory process” can recruit 
fibroblasts cells to the area, and allow the collagen and elastin fibers to form in the tissue 
in more of a parallel and organized manner, as described in laboratory rats.2,81 In humans, 
this maturation or “remodeling” phase of tissue can take up to 12 months to finalize.53 
Therefore, this may be reason that participants felt as if their foot pain continued to 
improve even after the treatment. 
 The results of the initial study of this dissertation are consistent with previous 
studies83-111 that demonstrate the possible benefits of IASTM for treating soft tissue pain 
and dysfunction of various pathologies. Specifically, this study results are similar to the 
case series by Looney et al87 in 2011, who had 10 CPHP participants receive Graston 
Technique, with nine reporting improvement and one not describing improvement to the 
treatment. One major difference between Looney and this study was this study was more 
consistent with Graston Technique treatment sessions, as participants were treated twice a 
week for six weeks per the Graston Technique Instruction Manual guidelines.1 The 
Looney et al87 study had participants receive treatment an average of 6.9 times once or 
twice a week for a range of six to eight weeks, due to the availability of the participants. 
Whereas both studies had similar outcome results, this study also disclosed that the 
majority of participants maintained or increased upon the positive outcomes for an 
average of two years from the posttest.  
 Currently in the literature there are four IASTM published studies that provide 
longitudinal follow-up from the cessation of Graston Technique treatment, three for 
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tennis elbow (lateral epicondylitis), and one for carpal tunnel syndrome. Sevier et al85 
described significant results with outcome measures for Graston Technique treatment for 
lateral epicondylitis compared to conventional physical therapy at 1, 4, 8 and 12 weeks 
from the start of treatment. Blanchette and Normand99 also found no difference for lateral 
epicondylitis with three month follow-up between Graston Technique and ergonomic 
training, however, both had positive outcomes from pretesting. Similar results were 
discovered in a pilot study by Burke et al98 during a three month follow-up where there 
was no difference in the improvement between manual therapy and Graston Technique 
for carpal tunnel syndrome. The longest longitudinal follow-up for an IASTM study was 
Sevier and Stegnik-Jansen87 in 2015, with lateral epicondylitis patients at six months and 
12 months. The participants were separated into an ASTYM group and eccentric exercise 
group, with the ASTYM group having greater gains in the disabilities of the arm, 
shoulder, and hand (DASH) outcome measure, VAS, and grip strength. The gains were 
maintained at the six and 12 months marks. 
 Whereas, the previous IASTM literature regarding longitudinal outcomes is for 
upper extremity conditions and has a duration of either three months or one year, this is 
the first longitudinal study specifically for CPHP, and has a duration of two years. This 
longer longitudinal duration suggests that IASTM provides a more permanent change to 
the tissues that otherwise may not occur with conventional treatment modalities, such as 






 A limitation of this study is the length of months it takes for CPHP to become a 
chronic condition. In 2012, DiGiovanni et al11 describes recalcitrant “plantar fasciitis” as 
lasting longer than ten months. The previous study for this dissertation used inclusion 
criteria of onset of symptoms of greater than three months, consequently, 6/15 (40%) 
participants had less than ten month onset of symptoms with a range of 3-9 months. 
While these participants had symptoms for less than ten months, the inclusion criteria 
also had a physician’s or podiatrist formal diagnosis of CPHP, rather than the judgement 
of the researchers. It is unknown if these participants would have spontaneously 
improved by the 10 month mark, however the participants went to a formal physician 
evaluation for the condition, therefore the symptoms were severe enough for further 
assessment. 
 Another limitation was the ability to control any treatments of the participants 
during the two year follow-up time period. While it was reported in this study, one 
subject continued Graston Technique with a local chiropractor, and one participant 
bought his own IASTM instrument and performs the technique on himself. Other 
participants reported performing their own plantar fascia specific stretching, or 
gastrocnemius/soleus stretching on their own. However, none of the participants sought 






Implications for Professional Practice 
 With CPHP affecting over one million patients a year63-64 it is a condition that can 
be often encountered at the rehabilitation setting. This case series demonstrates that 
IASTM may be an option as a beneficial treatment for patients suffering from CPHP. 
However, from the previous study, there were four out of 28 participants who dropped 
out of the randomized control trial due to pain from Graston Technique. It was 
hypothesized that two of the participants had a neuropathy due to their response to the 
treatment, with the other two suffering from hypersensitivity to the treatment. Therefore, 
due to the differential diagnosis, IASTM may not be for every case of CPHP, but for 
13/15 participants in this study, they had healthier pain and function outcomes as 
compared to pretesting. Also, the participants showed a trend of improved pain outcomes 
and maintaining functional activity, at the two year follow-up than the posttest. This is 
important, as some CPHP patients have the symptoms return with conservative 
treatments such as rest and a cortisone shot.3  
 Whereas there are contraindications for the Graston Technique,1 for most, it is a 
safe, non-invasive treatment for CPHP. Many of the participants of this study described 
that the first or second treatment sessions were uncomfortable, but they later described 
that they were able to get accustomed to it. As previously mentioned, IASTM may not be 
for all CPHP sufferers, as it may not be a plantar fasciopathy specifically, and quite 
possibly other differential diagnoses,22 such as neuropathy or nerve impingement 
syndrome, which IASTM may exacerbate symptoms. If the cause of the CPHP is a true 
plantar fasciopathy, this study agrees with the theory that IASTM may cause a controlled 
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inflammatory response.83,84 It may take up to 12 months for the plantar fascia to remold 
and completely remodel the collagen in the tissue,53 which was indicated by a majority of 
participant’s mild pain reported at posttest, and less pain at the two year follow-up. 
Future Directions of Research 
 With the increasing influence of evidence based practice6 for healthcare 
providers, it would be appropriate to recommend more randomized controlled trials 
utilizing IASTM. This would involve participants with the same condition being 
randomized into a treatment group, sham group, or control, and measuring the outcomes 
between groups. The results of the randomized controlled trials would be higher on the 
levels of evidence as compared to other studies. 
 While it is known that the plantar fascia thickens with CPHP,13,14 future research 
could utilize diagnostic ultrasound to measure plantar fascia thickness before and after an 
IASTM treatment regimen. This would truly measure if IASTM is effective in decreasing 
plantar fascia thickness from a pathological plantar fasciopathy to a functional and 
asymptomatic connective tissue.  
 Similarly, it has been previously mentioned of studies49,54,55 taking tissue biopsies 
of pathological plantar fascia tissue, and describing the degenerative changes to the 
tissue. Future research should examine biopsies of plantar fascias before IASTM 
treatment compared to after IASTM, along with symptoms and function. This could give 






 For some people, Chronic Plantar Heel Pain can be a very painful and debilitating 
condition that can persist for years. The results of this study suggest that Graston 
Technique treatment for CPHP provides for most, decreased pain and increased function 
not only at the end of a six week therapy protocol, but maintains the decreased pain and 
increased function over a two year longitudinal span. This study also suggests that with 
CPHP as a chronic fasciosis, the Graston Technique may possibly create a controlled 
inflammatory response in the degenerated tissue, which allow for proper tissue 
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APPENDIX B: THE MCGILL PAIN QUESTIONNAIRE 
The McGill Pain Questionnaire:  Some of the words below describe your present sensations. Circle 
ONLY those words that best describe it. Leave out any category that is not suitable. Use only a single word 
in each appropriate category - the one that best applies. 
 1     8       15 
 
Flickering    Tingling     Wretched 
Quivering    Itchy     Blinding 
Pulsing     Smarting 
Throbbing    Stinging          16 
Beating 
Pounding         Annoying 
      9    Troublesome 
 2         Miserable 
     Dull     Intense 
Jumping     Sore     Unbearable 
Flashing     Hurting 
Shooting    Aching        17 
     Heavy 
 3         Spreading 
      10    Radiating 
Pricking          Penetrating 
Boring     Tender     Piercing 
Drilling     Taut 
Stabbing    Rasping          18 
      
 4     11    Tight 
          Numb 
Sharp     Tiring     Drawing 
Cutting     Exhausting    Squeezing 
Lacerating         Tearing 
      12 
 5            19 
     Sickening 
Pinching    Suffocating    Cool 
Pressing          Cold 
Gnawing     13    Freezing 
Cramping      
Crushing    Fearful        20 
     Frightful 
 6    Terrifying    Nagging 
          Nauseating 
Tugging     14     Agonizing 
Pulling          Dreadful 
Wrenching    Punishing    Torturing 
     Grueling 
 7    Cruel 
     Vicious 






APPENDIX C: VISUAL ANALOG SCALE 
 
 
How severe is your plantar fasciitis pain today? Place a vertical mark on the line below to 
indicate how bad you feel your plantar fasciitis pain has been in the last 24 hours. 
 
                                           
 
                        No Pain                                                 Worst Pain Imaginable 





APPENDIX D: QUALITATIVE SCRIPT 
Explain how your chronic plantar heel pain affected your life before you started the 
study… 
-Pain -Function -Participation  -Activities of Daily Living 
 
When the study ended for you, how did the chronic plantar heel pain affect you? 
-Pain -Function -Participation -Activities of Daily Living 
 
Does your chronic plantar heel pain affect your life? 
-Pain -Function -Participation -Activities of Daily Living 
 
Explain things you couldn’t do before the study (because of your foot), that you can do 
now? 
Have you sought formal health care for your foot since the study ended? Type of 
Provider, diagnostic eval, therapy? 
 
Are you currently performing any self-treatment to your feet? Stretching, icing, massage, 
night splint, NSAIDs, etc? 
Any major life changes since the study that may affect your feet? 
 
Would you recommend the Graston Technique to a friend with the same condition?  
 
 
Looking back on your chronic plantar heel pain experience, what overall advice would 
you have for someone with the condition? 
